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Neurological diseases are a prevalent cause of global mortality and are of
growing concern when considering an ageing global population. Traditional
treatments are accompanied by serious side effects including repeated
treatment sessions, invasive surgeries, or infections. For example, in the case
of deep brain stimulation, large, stiff, and battery powered neural probes
recruit thousands of neurons with each pulse, and can invoke a vigorous
immune response. This paper presents challenges in engineering and
neuroscience in developing miniaturized and biointegrated alternatives, in the
form of microelectrode probes. Progress in design and topology of neural
implants has shifted the goal post toward highly specific recording and
stimulation, targeting small groups of neurons and reducing the foreign body
response with biomimetic design principles. Implantable device design
recommendations, fabrication techniques, and clinical evaluation of the
impact flexible, integrated probes will have on the treatment of neurological
disorders are provided in this report. The choice of biocompatible material
dictates fabrication techniques as novel methods reduce the complexity of
manufacture. Wireless power, the final hurdle to truly implantable neural
interfaces, is discussed. These aspects are the driving force behind continued
research: significant breakthroughs in any one of these areas will
revolutionize the treatment of neurological disorders.
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1. Introduction
Neural interface recording and stimula-
tion has been demonstrated as an effec-
tive diagnosis and treatment for numerous
neurological disorders.[1] With an empha-
sis on building closed-loop systems, mod-
ern neural probes must incorporate both
these functionalities while addressing the
disparate design requirements for different
types of electrodes, perhaps going so far
as to incorporate different modalities for
each task. As such, rapid growth has oc-
curred in this area of research, with several
distinctive and promising advances in neu-
ral probe design.[2] Bioelectronic medicine
is a fast-growing field, which seeks to es-
tablish new brain stimulation techniques,
while achieving two important goals: first,
to reduce negative side effects on the pa-
tient, and secondly, to mitigate technical
problems associated with the current de-
signs available for brain implants. As these
technologies have become more sophisti-
cated, the number of applications for neu-
ral stimulation have increased, now encom-
passing a wide range of neurological and
mood disorders, from Parkinson’s disease (PD) to depression. Al-
though the number of deaths from disorders such as epilepsy
and PD are declining, a concerted effort is required to improve
patients’ quality of life, especially when measuring disability-
adjusted life-years.[3] Innovative neurotechnologies focusing on
the recording and stimulus of brain activity could alleviate the
burden on sufferers and their caregivers. Recent emphasis on
flexible, miniaturized neural probes has shaped the latest gen-
eration of implant design. Only through optimizing each step in
the process of probe design and fabrication, robust and innova-
tive neural probes will be created, and carried into the future of
patient care.
In this progress report, the history of neural implants is ex-
plored, including the most recent and successful approaches, and
how they evolved from early technologies. The practicalities of
the neural probe, namely the shape and scale, have seen excellent
progress in recent years with the advent of tissue-like materials
and mesh electronics. In order to prevent an immune response,
the probes must mimic the flexibility, softness, and micron-scale
features of target organs/tissues. However, these characteristics
present a challenge in terms of implantation: a compromise must
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be found between flexibility and stiffness during surgery in order
to minimize unnecessary tissue damage.[4] A fully flexible probe
requires a potentially large area of the skull and dura mater to be
removed, which will hamper the healing process. Although probe
design has improved far beyond traditional silicon, wired probes
will always be limited, and prevented from integrating seamlessly
with the tissue.[5] Wireless, batteryless power represents a bottle-
neck for chronic implantation, and progression to the clinic.
2. Stimulation Methods
The emergence of neural stimulation dates from 46 C.E., when
electric ray fish were used to treat head pain,[6] while the 1950s
saw the first development of electroconvulsive therapies for some
neurological disorders. At the same time, researchers were start-
ing to use deep brain stimulation (DBS) techniques in animal
research, with the goal of electrically stimulating a number of
different parts of the brain. Satisfactory results in several areas,
including behavioral effects were found and thus, paved the way
for these techniques to be used on human participants.[7–9] Since
then, DBS has been a useful stimulation technique for numer-
ous neurological disorders.[1] However, unspecific electric stim-
ulation of the brain may obscure the true result of stimulating
the target tissue,[10] or have other severe complications that might
be overcome through the use of novel stimulation methods. The
use of these novel technologies could improve efficiency and re-
duce negative effects of brain electrical stimulation. In the last
decade, optogenetic technology has emerged as a new opportu-
nity to solve the issues associated with electric stimulation. How-
ever, it is still in development and not commercialized for human
use. In this section, the main technical aspects of those stimu-
lation methods are described, indicating why some techniques
have fallen out of favor with clinicians.
Among the numerous obstacles shaping the design of neu-
ral implants, the most important are: difficult accessibility to
the implantation site; viscoelastic properties of the brain; tis-
sue dimpling and scattering due to the injection force during
probe implantation; density mismatch between the probe ma-
terial and brain tissue and the physiologic fluid; and apparent
recording site impedance.[11–13] Those five restrictions are com-
piled in Figure 1. Material choice and electronic design are two
factors that will determine the biocompatibility and long-term vi-
ability of the implantable device which are dictated by the stimu-
lation technique.[11,12] More precisely, mechanical properties are
the main concern of most research in this field.
Neural stimulation probes typically incorporate a conductive
material, such as gold.[14] Although it is an inert material, and its
toxicity is very low to the body, ensuring a biochemical compat-
ibility with the brain tissue,[15] the reality is that in mechanical
terms, size matters. This highly determines the long-term viabil-
ity of the implant functionality. Using these data presented here
and given the design constraints of this implant typology, several
conventional therapies will be introduced, as well as the progress
on the designs trying to overcome those restrictions. These thera-
pies range from the oldest and least common technique, such as
electroshock, to the most novel therapy in development, such as
microscopic magnetic stimulation (𝜇MS). Breakthroughs in the
various electronic, magnetic, and optical stimulation techniques
which have evolved over the decades are summarized in Figure 2.
Figure 1. Pentagon of design constraints of brain implants. Accessi-
bility to implantation site, density mismatch, apparent recording site
impedance, force and tissue insertion dimpling, and the brain tissue vis-
coelasticity are the main issues to overcome during the design of brain
implantable device in chronic implantation.[11]
While a range of techniques have been developed over the past
decade to modulate and record neural activity, Figure 2 details
how miniaturized electrical probes have developed alongside
alternative methods. Despite the benefits of emerging technolo-
gies, significant effort is still expended by the research commu-
nity to improve the design of electrical probes. In recent years, es-
pecially, major strides have been taken towards fully implantable
chronic recording probes, with a view to creating closed-loop
systems which do not recruit an immune response in the future.
2.1. Electroconvulsive Therapy
During the 1940s, a technique called electroconvulsive therapy
(ECT; Figure 3A) appeared as a novel intervention method for
the treatment of major depressive disorders and severe mood
illnesses.[16] During ECT, also known as shock therapy, a small
electric current is delivered through electrodes into the brain trig-
gering a brief seizure and neurochemical changes. It was consid-
ered very effective in terms of time and resources, since chemical
treatment was not required. Strides have been made in the field of
ECT over the decades. In fact, it is considered the most successful
treatment for severe treatment-resistant depression.[17] Despite
this, the preconception of ECT is generally poor,[18] despite its ef-
ficacy and improved safety.[16] Though this therapy has fallen into
disuse, it is still considered in cases where the resources are lim-
ited, or clinicians are seeking to reduce the invasiveness of the
treatment and avoid surgery.
An alternative type of ECT, the focal electrically administered
seizure therapy (FEAST) was designed to achieve a better degree
of focality and of efficiency of the electric pulse in order to miti-
gate the potential side-effects of the therapy,[19] such as headache,
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Figure 2. Significant publications in the field of neural stimulation, which illustrate the place of electrically stimulating probes amongst the development
of alternative techniques. The upper section includes such important designs as: the Michigan probe,[360] the Utah Array,[361] Polymeric probes,[362] Mesh
Electronics,[296] and Neuropixels.[140] The lower half of the timeline includes Electroconvulsive Therapy,[363] Deep Brain Stimulation,[364] Transcranial
Magnetic Stimulation,[365] Optogenetics,[366] Vagus nerve stimulation (VNS),[367] FEAST,[21] and 𝜇MS.[33]
muscle pain, and memory loss.[20] From initial animal studies,[21]
this technique was regarded as a promising anticonvulsant.
2.2. Transcranial Magnetic Stimulation
Transcranial magnetic stimulation (TMS; Figure 3B) is a power-
ful and painless procedure frequently used both in clinical and
research practices to shed light on movement, vision, language,
and neurological disorders.[22–24]
This technique involves a localized magnetic field focused on
the brain capable of modulating cortical excitability (either in-
creasing or decreasing it).[22] Depending on the frequency, num-
ber of pulses, train duration, and intertrain intervals, the induced
current activates a wide variety of neurophysiological and/or be-
havioral effects producing a benefit on the patient’s brain.[23]
Nowadays, TMS seems to be relevant also for therapeutic prac-
tices in neurology, rehabilitation and psychiatric conditions, such
as chronic depression and substance abuse disorders.[25,26]
A modification to the previous technique is the repetitive tran-
scranial magnetic stimulation (rTMS; Figure 3B) that involves
prolonged and repeated magnetic stimulation (MS) of the brain
through the scalp.[27] During the rTMS treatment the magnetic
coils switch polarity, with a period in the order of microseconds.
This process creates a strong magnetic field, which in turn pro-
duces an increased response in the brain: this therapy is both
efficient and fast.[27] Depending on the frequency of the mag-
netic field applied, different areas of the brain will be stimulated
with different intensities, and dictates whether the target region
is inhibited or excited.[28,29] For example, using a 10 cm circular
coil and targeting the cerebellum, it is possible to stimulate that
region exclusively through proper antenna positioning. rTMS is
used for anxiety and depression in people with treatment resis-
tant depression,[30] for postural control in people with spinocere-
bellar ataxia,[31] and to reduce seizures.[29]
2.3. Micromagnetic Stimulation
Following the extensive interest surrounding optogenetics (see
Section 2.5) in the research community, there has been investiga-
tion into the feasibility of magnetogenetics, in which genetically
modified tissue would be receptive to magnetic stimulation.[32]
While this technique is still in its infancy, alternatives exist which
have progressed beyond TMS: namely, 𝜇MS from implantable
microcoils (Figure 3C). Numerous benefits arise from using𝜇MS
over the conventional electrode-based stimulation. Firstly, the ac-
tivity of selected neuronal subpopulations is better controlled
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Figure 3. Summary of the four main brain stimulation techniques based on electrical systems. A) Electroconvulsive Therapy is the most conventional
technique, which was replaced by B) Transcranial Magnetic Stimulation for some specific cases of neurological disorders. C) Micromagnetic stimulation
requires the implantation of a miniaturized magnetic coil which will not be hindered by immune cell encapsulation. D) Deep Brain Stimulation systems
are the most used like commercial products, e.g., Neuropace, Medtronic VNS, and so on. E) Optogenetic stimulation has appeared as an innovative
and interesting opportunity during the last decade with the use of Chr2.
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due to the spatially asymmetric magnetic stimulation.[33,34] Sec-
ond, the coil encapsulation with materials which have previously
been designated as biocompatible, such as parylene[35] and liquid
crystal,[36,37] may reduce the neuroinflammatory response. Elec-
trode performance degrades over time due to corrosion, and the
increasing distance between the probe and its stimulation target,
due to scarring and neuronal death. By contrast, magnetic fields
are permeable to tissue and biological materials, and the coils
will remain as effective stimulators in spite of the immune re-
sponse and the scar formation.[38,39] Furthermore, avoiding the
direct contact of the metal coil with the host tissue, this system
overcomes several complications caused by the tissue-electrode
interface.[40–43]
A fully encapsulated mm scale coil was tested in vitro, and con-
firmed to stimulate retinal ganglion cells.[33] Miniaturization ef-
forts yielded a coil measuring 500 µm in diameter × 1 mm long,
which is comparable to the state of the art in electronic probes
even for those implanted both in the cortex and deep subcorti-
cal nuclei. Successful stimulation with high selectivity was pro-
duced by altering the orientation and the magnitude of the coil
relative to nearby neurons.[38] The most attractive feature of im-
plantable magnetic stimulation is the long-term reliability and
the fact that they are Magnetic Resonance Imaging (MRI) com-
patible due to a good electrical insulation of the coil that limits
the heating induction.[33] Concerns about the heat produced by
the coils during operation have been addressed using finite el-
ement method (FEM) simulation which report that the temper-
ature would not increase above 39 °C in the brain.[39] However,
following the example of DBS electrodes, the maximum allow-
able increase is 1 °C.[44]
2.4. Deep Brain Stimulation
The most extensively employed technique for neurostimulation
is DBS (Figure 3D). It is an established treatment option that in-
volves the placement into the brain of a medical device, also called
“brain pacemaker,” for the improvement of motor problems as-
sociated with PD, essential tremor, and dystonia,[45] as well as
conditions including, but not limited to, epilepsy and clinical
depression.[46,47] Pulses that mimic the natural flow of impulses
are used to electrically stimulate neural pathways of specific areas
of the brain (typically the motor cortex or cerebellum)[46] provid-
ing motor function restoration, improvement in quality of life,
and adequate control of movements in PD patients. However, this
treatment is not suitable for every patient and thus, its success de-
pends on the patient’s condition.[48] Electrodes may be inserted
either side of the basal ganglia, or on one side only. Typical im-
plantation sites are the subthalamic nucleus (STN-subthalamic
stimulation) or globus pallidus internus (GPi– pallidal stimula-
tion), but the thalamus (thalamic stimulation) can also be a tar-
get location. Leads extended from the implanted pulse generator
to the stimulating probe are often a cause of repeated surgeries,
as they require position adjustment, treatment for skin erosion
or infection, or replacement due to lead fracture.[49] This is a po-
tentially negative outcome of this implant typology. A typical DBS
device includes a battery that supplies the controller and provides
enough energy for the stimulation. As expected, there are many
issues associated with this implant. Despite the necessity of MRI
for many DBS patients, increased brain tissue temperature and
current through the device represents a significant risk, as indi-
cated by researchers’ efforts to review the hazards and collate best
practice techniques to reduce patient harm.[50] For example, finite
element models may be used to evaluate the specific absorption
rate (SAR) and heating experienced during MRI, without poten-
tially endangering patients.[51]
The bioheat equation was first coined by Harry H. Pennes in
1948 and this equation models the changes in temperature of
a human tissue considering parameters such as tissue density,
tissue specific heat, temperature, time, tissue thermal conductiv-
ity, volumetric heat source (Qv), heat loss due to perfusion (Qp),
and metabolic heat generation (Qm).
[52] The Qv represents the
effect of electromagnetic fields associated with transcutaneous
energy transfer and transcutaneous telemetry. The Qp term is
the heat loss of the perfusion and how the cooling effect of the
blood vessels affects to the temperature of the tissue. Finally, Qm
term is the metabolic heat generated by the tissue as an effect
of the metabolic changes. For instance, brain tissue metabolic
changes can vary from 0.5 to 4.0 nW depending on location and
level of activity.[52] In addition, the length of the implanted leads
increases the likelihood of mechanical defects and immune re-
sponse. The rigid, sizeable components used in a typical DBS
system prevent successful biointegration.[11,12,53] Although DBS
in its current form is the most adopted technique, important ad-
vances are being made in order to address biocompatibility is-
sues. The latest advances in wireless power transmission systems
provide an opportunity to remove implantable batteries from the
system entirely.
2.5. Optogenetics
Optogenetics is a photostimulation procedure which aims to
achieve specific stimulation of the brain tissue, integrating op-
tical and genetic detection techniques. It has been established
as a promising alternative to traditional electrostimulation (Fig-
ure 3E). This novel method utilizes light-sensitive proteins, such
Channelrhodopsin-2 (Ch2) which naturally occurs in Chlamy-
domonas reinhardtii alga.[54] It is possible to genetically modify
the specific neurons which will be the target of the stimulation
with lentiviral gene delivery of this protein. Action potentials oc-
cur on the target cells in response to light stimulus characterized
by a specific wavelength. The main advantage of this technique
is its specificity.[55] This is further explored in a review by Won
et al., which discusses how electrostimulation cannot focus as ef-
fectively on cells or small brain regions.[56] Different levels of tis-
sue penetration are enabled by different wavelengths, while the
target neurons may be stimulated or inhibited exclusively accord-
ing to their genetic modification, with the absence of conducting
wires on the brain tissue. Exposed stimulating electrodes may be
the site of irreversible reactions as described further in Section 4.
In their place, optogenetic systems utilize micro-light emitting
diodes (LEDs), which are often coupled with waveguides. How-
ever, micro-LEDs have their own negative effects without care-
ful duty cycle control, such as tissue heating.[57] Replacing wires
and probes with micro-LEDs and optical waveguides removes the
need for stimulating electrodes, which may be the site of irre-
versible reactions as described further in Section 4 Emerging
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Figure 4. A) Immune response in the wake of rigid probe implantation. Astrocytes and Microglia adhere to the probe surface, as the foreign body
response seeks to encapsulate the implant to protect tissues from further harm. Dystrophic neurons, which have been separated from neuron clusters
and suffer degradation, will amass around the probe. B) Reduced foreign body response elicited by a flexible polymer probe. C) The plasma membrane
on the outside of a cell is attached to *extracellular matrix (ECM) which is comprised of the proteoglycan complex and collagen fibers.
technologies in the field of biochemistry will lead this new
wave of stimulation techniques based on the protein-function
specificity.[55] Using a wide range of light-dependent-proteins and
optoelectronic devices, it is possible to stimulate specific neurons
instead of whole areas of the brain.[55,58,59] Particular emphasis
must be placed on the light penetration into the brain tissue.
Since there are many factors that determine the light penetration
in a biological tissue, such as tissue density, light wavelength or
power of the light source. Tedford et al.[60] report a maximum
light penetration of 45 mm from the light source into the brain
tissue. The light source must be placed over the tissue as close as
possible. In their report they used a 808 nm wavelength and 5 W
laser.
In order to improve the penetration depth, near-infrared (NIR)
light has been used in optogenetic systems, moving away from
the traditional LED-based geometry. A detailed review was carried
out by Yu et al., discussing how NIR light may be converted to vis-
ible light or heat inside deep brain regions, for the purposes of
optogenetic or thermal stimulation.[61] Light stimulation seems
to be a very promising technique, removing the need for inva-




In order to understand the best design practice for implantable
neural probes, it is important to understand the mechanism
of the foreign body reaction (FBR), which may require up to
a month to stabilize after implantation,[12,62,63] though in some
cases the FBR has lasted a number of years.[11] While the
brain microenvironment is tightly regulated and protected by
the blood-brain barrier (BBB), neural probe implantation itself
causes physical damage of host tissue (drilling into the skull,
piercing the dura mater, and compromising the BBB and the ex-
tracellular matrix), which in turn induces an acute neuroinflam-
matory reaction, known as FBR.[64] The FBR process involves the
activation of the tissue-specific innate defenses, microglia and as-
trocytes, and their transition from a resting into a reactive state,
and drive peripheral immune cells (i.e., macrophages) to enter
into the insulted area.[12,62–65]
This process is illustrated in Figure 4A. While microglia and
macrophages locally deliver several proinflammatory molecules
(e.g., cytokines, chemokines, interleukin-1, nitric oxide, tumor
necrosis factor),[65,66] astrocytes, connective tissue and extracel-
lular matrix are primarily employed to the formation of a fibrous
envelope, attempting to encapsulate the unfamiliar and poten-
tially harmful device.[13] Glial scars seek to defend the tissue sur-
rounding a given implant displacing the neurons that are going
to be recorded and/or stimulated;[67] further, the scar is also inter-
penetrated with neurotoxic factors released from both microglia
and astrocytes which hinder the regrowth and the recovery of tar-
get tissue.[13,41]
The device/tissue crosstalk communication could also be af-
fected in a long term phase due to the induction of the adaptive
immune responses that could also be triggered by the implant
deterioration (e.g., the change in the surface properties)[68] com-
promising the device performance over time. This has major con-
sequences for the noise of the recording, whereas for stimulation,
a higher voltage will be required to excite the neurons.
Another important factor is related to the impact of aging that
physiologically affects several features of the brain tissue, in-
cluding the degeneration of neurons and oligodendrocytes,[69]
the viscoelastic properties of the cellular matrix,[70] and the
immunosenescence.[71] These factors point some questions con-
cerning the research of a proper design and biomaterials to sat-
isfy different needs and diverse brain tissue response in terms of
acute and chronic inflammatory reaction in aged versus young
individuals.
The major challenge embraced by material science in devel-
oping neural interfaces is to understand the best design practice
to improve the biological compliance with a view to minimize
the initial trauma of healthy tissue and neuroinflammation in fa-
vor of the device-host tissue interaction, and prolong the implant
performance.[72]
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3.2. Extracellular Matrix
The extracellular matrix (ECM) is a very dynamic meshwork of
molecules, comprised of proteins and sugars (glycans),[13,73] re-
leased by neurons and glia in the interstitial space of tissues,
as shown in Figure 4B. It has features that vary in size from 50
to 500 nm,[74,75] constituting 10–20% of brain volume.[74–76] The
ECM provides mechanical support to the structural organization
of neuronal network and chemically sustains the normal physiol-
ogy of the central nervous system (CNS), in terms of cell viability
and neuronal activity.[74,75] It orchestrates several signaling pro-
cesses throughout the development of the neural system and in
the maintenance of synaptic plasticity in the adult mature brain.
Pathological events that impair the normal ECM functions have
been found to be linked with a wide range of neurological and
psychiatric conditions, such as epilepsy[77] and schizophrenia.[78]
Moreover, the ECM plays an active role during neuroinflamma-
tion processes.[79]
Considering that, tissue engineering employs ECM-based ma-
terials for neural interfaces with the intent of simulate a substrate
closer to the neuronal habitat in order to mitigate the immune
response, reducing the scar formation and preventing cell death.
The ECM coating includes a range of potential scaffold materi-
als based on man-made (e.g., Poly (ethylene glycol), PEG; Poly
(glycolic acid), PGA; Polypyrroles (Ppys) and natural (i.e., colla-
gen, fibrin, fibronectin, and hyaluronic acid) substances.[80] The
application of these materials depends on a host of physical and
chemical characteristics. They have to be biocompatible and able
to fit in the implantation site promoting the most favorable cell
conditions. Moreover, these scaffolds should allow the optimal
crosstalk communication with neural cells and ensure the long-
term device performance.[74,75,80,81]
Neural implants which seek to mimic the composition of the
ECM encourage neuronal penetration and regeneration, espe-
cially when employing polymers.[12] This is of particular interest
to tissue engineers, who focus on marrying biological scaffolds
with cells for implantation in order to sustain the tissue integra-
tion and repair taking advantages of the molecules secreted from
these cells which constitute the hybrid.[73] Some of the most suc-
cessful neural probes exploit a mesh-like structure, with only 20%
of the total surface area comprised of flexible substrate.[82] Much
like the support provided to neurons by the ECM, mesh probes
encourage neuronal penetration.
3.3. Feature Size
Even if the implantation of an extraneous material always elic-
its a tissue reaction,[83] there is ample evidence to suggest that
limiting the dimensions of a neural probe to cellular or subcellu-
lar scale is the best practice to circumvent an immune response
and provide a more accurate tissue integration and stimulation
in a target area of the brain.[84] Looking beyond the immune re-
sponse, a smaller probe offers several other advantages in terms
of tissue displacement impact, minimizing the steric blockage of
signaling molecules and changes in the intracranial pressure due
to the device volume in the host tissue and because of the pene-
tration trauma and a possible complication caused by vasculature
disruption, diminish the consequences of a cerebral edema that
may be fatal.[85–87] There is also concern over the performance
of neurons following implantation: damage which extends over
centimeters is likely to be permanent, as axonal recovery and
regrowth has its limitations.[67] While reducing the footprint of
the device can have negative consequences for the impedance of
the electrodes, coatings with organic conductive polymers such
as poly(3,4-ethylenedioxythiophene):poly(styrenesulfonate) with
carbon nanotubes (PEDOT:PSS/CNT)[88] may compensate for
this, increasing the charge transfer capacity.[89]
In this regard, other materials such as iridium oxide,[90] amor-
phous silicon carbide,[91] and ruthenium oxide,[92] which exhibit
high charge injection capacity and low-impedance coatings have
been recently gained ample attention for the development of mi-
croelectrodes with both neural recording and stimulation perfor-
mance.
3.4. Anchorage and Micromotion Dependence
As discussed in-depth in a review by Discher et al., anchorage
dependent cells require a solid substrate to adhere to: in vitro,
both neurons and astrocytes are discerning when it comes to
substrate stiffness, and their growth is affected accordingly.[93] In
fact, based on the differences in the biomechanical properties of
neuronal and glial cells, while neurons in vitro grow well on soft,
flexible surfaces, astrocytes fare better on rigid materials.[94] In-
vestigation into neuronal growth on poly(acrylic acid) (PAA) gel
uncovered the fact that neurons successfully produce neurites,
whereas glial growth was nonexistent.[94] Methods of producing
stretchable substrates include metal deposition onto a material
surface while it is being stretched, or serpentine layouts,[73] and
as such there is opportunity to further investigate the effects of
flexible substrates on neuronal growth in vivo.
Together with anchoring, the chronic stability of a neuro-
morphic device is influenced by micromotion. It is defined as
small movements (i.e., submicron to micron) of the foreign tool
in the native tissue related to several factors: mechanical inter-
actions between the surrounding tissue and the electrode in-
terface (mechanical sources),[95] vibrations associated with en-
tire body motion (behavioral sources)[96] and movements caused
by cardiac rhythm, breathing and vascular pulse (physiological
sources).[97,98]
Reinforcing the connection between the implanted device and
the neural tissue, for example acting on the mechanical features
of the materials, may contribute to the stability of the implant,
decreases the microdamage and reduce the stress and strain at
the electrode–brain interface as well as the FBR response at early
stages.[99–101] Finite element modelling has been used to suggest
that an implant that moves with the brain tissue, for example in
the case of neuronal interpenetration, will cause less damage due
to micromotion: this requires significant validation in vivo before
it may be treated as a design recommendation.[102]
As discussed in the design recommendations in Section 9.4.,
there is a case to be made that wired or tethered brain im-
plants can have a significant impact, not only on the micro-
motion inside the brain,[103] but the natural behavior of ani-
mals during experiment.[58] Extensive research has been carried
out by academic groups lead by Rogers,[104–106] Sheng,[107] and
Degenaar,[108] among others, on the development of wireless
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optogenetic probes. The breadth of work on the subject shows
that the design effort required to remove wires is beneficial
enough to incorporate into numerous systems. Working towards
fully integrable neural implants, probes have been designed to
“float,”, i.e., be tethered to connections outside the skull only by
a thin and flexible polyimide cable.[109,110]
3.5. Nanopatterning
The surface of the brain is not perfectly smooth: in an attempt to
integrate successfully with neural tissue, implants will often be
patterned with nano- or micronscale features. Different features
of a neural probe surface, such as the topographical and rough-
ness characteristics, may weaken the immune process,[111–113]
and improve chronic tissue integration. Detailed design strate-
gies of the surface can provide a street map for in vitro
nerve regeneration influencing the direction and extent of neu-
ronal growth, which can be accomplished by molding polymers
such as Poly(dimethyl siloxane) (PDMS) or polystyrene-block-
poly(ethylene-ran-butylene)-block-polystyrene (SEBS).[114,115] For
example, the depth of a channel dictates whether a neuron in vitro
will grow along it, or orthogonal to it; axons grow more readily on
raised areas compared to channels; and the radius of a fiber can
shape the formation of neurites.[116]
3.6. Biological Coatings
Probe coatings have many uses, most commonly the modifica-
tion of stiffness during implantation. However, they can also be
biofunctional: as the coating degrades, drugs or even living cells
will be exposed to the surrounding tissue, which can help to pre-
vent inflammation, or aid integration.[89] Typically, a hydrogel
is employed to slowly and harmlessly degrade inside the body,
and is attractive in terms of its noninterference with electronic
recordings, and because a chosen layer thickness is easily repro-
ducible. Hydrogels must be selected to degrade at an appropri-
ate rate to prevent them from drawing in fluid from the sur-
rounding tissue.[117,118] A “living scaffold”[119] is described as a
regenerative scaffold which combines living cells organized in
3D topology and biomaterials which can be used to replenish
the cells in an area where tissue has been damaged,[67] for ex-
ample, areas of neuronal loss following implantation of a probe.
The scaffold itself should be engineered to assimilate to the tar-
get tissue, encourage axonal growth, and provide structure for
cell proliferation.[119] There is some concern around the immune
reaction to any foreign cells introduced into the scaffold; how-
ever, stem cells are reported to mitigate inflammation, and en-
courage tissue restoration.[62] Glia in “proregenerative states”[120]
may also help to protect neurons from the detrimental effects of
the FBR. The “living scaffold” is taken one step further with the
advent of “living electrodes” or “micro tissue engineered neural
networks”[72] which shows significant progress towards artificial
neurons which integrate harmoniously with real neurons.[117,118]
Oxidative stress due to implanted microelectrodes represents
another important aspect in neurodegeneration also influenc-
ing the device functioning.[121] Use of antioxidative coating,
such as small interfering RNA-mediated gene silencing for
specific genes,[121] and superoxide dismutase (SOD) mimetic
Mn(III)tetrakis (4-benzoic acid) porphyrin (MnTBAP),[122] may
represent new therapeutic strategies to reduce the force of neu-
roinflammation and reactive oxygen species (ROS) production
targeting on specific inflammatory pathways.
3.7. Hydrophobicity/Hydrophilicity Chemical Properties
The permeability of a medical device surface in terms of hy-
drophobicity and hydrophilicity is a critical material property that
influences the energetic interactions between the outer face of
the device and the protein, making the surfaces capable of inter-
fering with the protein absorption.[111]
Biomaterial hydrophobicity could determine immunoge-
nicity[123,124] through the recognition of the hydrophobic moi-
ety of biological molecules by the immune system as a marker
of a potentially harmful signal pathway.[123] Hydrophobic sub-
strates, in an aqueous biological medium, leads to disorder in
the entropy of water molecules in favor of protein adsorption
and aggregation to the biointerface. In this view, following the
immune response, proinflammatory molecules, and neurotoxic
cytokines are absorbed more extensively on the surface of such
materials, and inflammation is increased over time perpetuating
the chronic response.[125] It has been suggested that hydrophilic
coating may upgrade the biocompatibility by creating a water-
attracting surface, and diminishing the amount of absorbed pro-
tein compared to a hydrophobic interface.[126–128] Moreover, the
functional groups that are exposed on the material surface can
differently affect the biological compliance of a device. The most
represented are methyl (–CH3), amino (–NH2), hydroxyl (–OH),
and carboxyl (–COOH) groups.[129]
There is some debate about the possibility that the surface
charge may modulate the protein adsorption and their fold-
ing more than the physical properties of hydrophilicity and hy-
drophobicity, and as a consequence are integral to the immune
response. In brief, the hydrophobic and neutral-charged –CH3
moieties show to amplify and sustain an inflammatory response
accompanied by increase in the scar thickness.[130] Among the hy-
drophilic functional groups, –NH2 (which is positively charged)
and –OH (neutral), elicit acute inflammatory response, cell in-
filtration and long-term in vivo fibrotic reactions[131] even if only
–OH shows lower protein affinity while –NH2 reveals to enhance
protein adsorption and denaturation.[132,133] On the contrary, the
hydrophilic and negatively charged –COOH group may mitigate
glial scarring and cell infiltration.[131] These attributes are sum-
marized in Table 1.
In order to allow an implanted electrode to be effectively in-
tegrated in the host tissue, it is necessary to implement some
strategies to reduce unsuitable tissue responses through proper
surface modification techniques that remodel physical and chem-
ical features of the implant outer surface.[120]
Since nonspecific protein adsorption has been suggested to
give rise to an inflammatory response, for example Zwitterionic
poly (sulfobetaine methacrylate) (PSB) and polydopamine (PDA)
coated implants have been recently investigated as a promis-
ing material sharing a hydrophilic nature, to promote a reliable
electrode-tissue interface and suppress microglia activation and
neuronal loss.[134] Further, graphene-based flexible microprobes
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Table 1. Summary of most common molecules on the surface of a biomedical implant, and the consequences of the presence of these groups.
Group Hydrophobicity Charge Action in the body Reference
–CH3 (methyl) Hydrophobic Neutral Inflammatory response, increased scar thickness
[130]
–NH2 (amino) Hydrophilic Positive Inflammation, cell infiltration, fibrotic reactions
[131,132]
–OH (hydroxyl) Hydrophilic Neutral Inflammation, cell infiltration, fibrotic reactions [131,133]
–COOH (carboxyl) Hydrophilic Negative Glial scarring and cell infiltration [131]
may be used for the detection of neural and cardiac recordings.
In particular, the hydrophilization treatment by introducing hy-
droxyl groups on graphene outer surface made the microelec-
trodes suitable for biological applications.[135]
Despite the fact that a modified, hydrophilic film may help to
restrain the FBR,[136] most of the common polymers employed
in the fabrication of neural probes are, indeed hydrophobic (e.g.,
parylene-C, SU-8 and PDMS), but still largely biocompatible. As
concluded by Lee et al.,[63] the effect of hydrophobic groups on
the surface of these polymers may, in reality, have an insignifi-
cant effect on the FBR. In the case of SU-8, surface modification
to increase the hydrophilicity aids in the delivery of mesh elec-
tronics in solution, delivered through a syringe.[137]
4. Probe Design
4.1. Recording and Stimulating Electrodes
When seeking to both record and stimulate a target area of the
brain with a single electrical probe, it is crucial to understand
the difference in design requirements for the two functionali-
ties. Characteristics of a selection of recording, stimulating and
bidirectional probes are summarized in Table 2. Microelectrodes
must achieve a high charge injection capacity (CIC), and are often
physically larger and produced with different materials compared
to recording electrodes, for example sputtered iridium oxide,[138]
or PEDOT:PSS coating.[139]
Barz et al.[109] and Schander et al.[110] both combine polyimide
ribbon cables with silicon stiffened shafts. While Barz has record-
ing electrodes limited to 25 µm diameter, the maximum stimu-
lating electrode area used by Schander is 4000 µm2. As an over-
all size comparison, the stimulating silicon probe (130 µm wide,
30 µm thick) is less than double the width and of comparable
thickness to the Neuropixels probe from Jun et al., which mea-
sures 70 µm by 20 µm.[140] High electrode counts, such as those
displayed by the neuropixels probe, provide the opportunity to
record activity from multiple neurons at once. This may pave the
way for greater understanding of how groups of neurons, and
potentially even multiple brain regions, work in tandem.[141]
When considering polymers, Tooker et al. employ a polyimide
substrate for their recording and stimulating probe, with multi-
ple metal layers.[142] Similarly, the impressively dense, parylene
probe from Scholten et al. uses an electrode bilayer, also with
platinum metallization.[143] The bidirectional probe boasts elec-
trodes with varying diameters between 10 and 100 µm, while the
recording probe is limited to 30 µm. However, the comparison in
Table 2 indicates that neither were fully evaluated in vitro.
The volume of tissue activated by a neural probe is correlated
to its size,[84] and the intensity of the stimulus.[144] Once it has
been confirmed that a probe will excite nearby neurons, it is nec-
essary to limit the stimulation magnitude to prevent electrolysis
in the biofluidic environment, tissue damage and degradation of
the electrodes themselves.
Significant effort has been expended to ensure the safe opera-
tion of neural stimulus systems, such that researchers may pre-
vent irreversible reactions at the electrode and harm nearby tis-
sue. In order to modulate the charge injection from an electrode,
current control is used commonly, but not exclusively.[145] The
significance of the Shannon criteria, which are used to set the
maximum stimulation amplitude, cannot be overstated.[146] This
prolific work is used to define the parameters for countless neural
probe experiments, and has been the basis for further investiga-
tion into tissue damage during microelectrode stimulation.[43]
4.2. Corrosion and Irreversible Reactions
As part of electrode characterization, accelerated electrical aging
requires that a significant number of cycles (for example, 3.5 bil-
lion) be performed on the implantable device to investigate elec-
trode corrosion.[147] The maximum applied voltage which avoids
electrolysis of water is 1 V,[148] although cyclic voltammetry is of-
ten carried out at marginally lower voltages. A definitive study car-
ried out in 1974 concluded that iridium and platinum are among
the most robust electrode materials in terms of corrosion,[149]
and as such are preferred over gold. Despite this, gold is still
commonly used either as a track metal,[150] or as the electrode
itself.[151–153] In contrast, silver is considered to be toxic and is
unacceptable as an electrode material.[154]
The interface between electrodes and brain tissue is through
electrical stimulation, as covered before. However, neural com-
munication in the brain occurs through ion transfer in an elec-
trolytic tissue media, more specifically through neurotransmit-
ters that activate and deactivate ion channels in the neurons cell
membranes.[155–157] The effect of the local field potential created
by the electrodes produces dynamic changes in terms of ionic
movements in the surrounding tissues. These movements trig-
ger firing of excitable cells by the depolarization of the transmem-
brane voltage of the targeted neurons and ionic currents in the
surrounding tissue. During stimulation, increased voltage can
accelerate the process of corrosion of the materials (i.e., electrode
degradation) or even produce changes in the conductivity of the
surrounding neurons, a phenomenon intensively studied since
it is one of the main failure issues of neural probes.[11,43,53]
Relatively high voltages can unbalance redox reactions on the
tissue surrounding the electrode and accelerate the corrosion of
the materials used. In addition, depending on the shape of the
electrodes, other phenomena such as the appearance of bubbles































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Adv. Sci. 2021, 8, 2002693 © 2021 The Authors. Advanced Science published by Wiley-VCH GmbH2002693 (10 of 33)
www.advancedsciencenews.com www.advancedscience.com
Figure 5. A) Young’s modulus on log scale for brain tissue and neural probe materials, with silicon as the stiffest common substrate. B) The effective
bending stiffness values of the most relevant implantable probe styles.
around the electrode interface due to the electrolysis that can in-
sert oxygen bubbles into the electrode interface or the appearance
of double layers of shielding tissue that produces changes in the
impedance of the surrounding tissue thus affecting negatively to
the stimulation efficiency.[11,12,158]
4.3. Failure Modes
There are two avenues of failure for an implanted probe,
which are inextricably linked. The first is a prolonged and vig-
orous immune response, which takes the form of glial scar-
ring, the proliferation of astrocytes, microglia accumulation and
inflammation.[159] Eventually, neurons in the surrounding area
will begin to die. Scar tissue will increase the impedance between
the electrode and the targeted neuron, and the signal-to-noise ra-
tio (SNR) will decrease.[160] These responses are primarily caused
by surgical trauma[161] and micromotion after implantation.[162]
Achieving low impedance requires compromise in terms of in-
creased probe surface area, in accordance with the resistivity
equation. As such, the immune response is largely affected by
the first two criteria: scale and shape.
The second failure method involves the mechanical or elec-
trical failure of the probe itself, mainly through delamination
or fracture, which is exacerbated by surface defects such as
microcracks.[163] Improved fabrication, not limited to techniques
which ensure the reliable adhesion of substrate and conductor,
reduces the risk of delamination. Thermal annealing is a useful
method to accomplish this for parylene layers,[164] while surface
roughening,[110,165] or liquid adhesion promoter may be used for
polyimides,[166] depending on the second material the polyimide
layer is attached to. Encapsulating the probe serves to increase
the buckling strength compared to uncoated probes.
However, careful consideration must be made before selecting
the encapsulation material. Without sufficient stiffness, the im-
plant cannot be inserted into the brain; if the Young’s Modulus
of the probe is much greater than that of brain tissue (in rodent
and human brains the E value has been identified in the range of
0.1–16 kPa),[167–170] trauma is more likely to occur. In Figure 5,
the Young’s modulus of implant topographies is compared,
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alongside the bending stiffness of materials employed histori-
cally in neural probes. Further to this, the optical characteristics
must be explored,[171] while novel prospects such as drug delivery
or medicinal properties also bear consideration.[172]
4.4. Miniaturization and Material Selection
Miniaturization of the implantable neural device allows the elec-
tronics to conform more closely to the surrounding tissue, and re-
sults in greater compliance, at the cost of considerable reduction
of the buckling force. Reducing the thickness of stiff, e. g. silicon-
based probes, with high Young’s modulus, reduces the dispar-
ity between the probe and neural tissues. The size of the probes
made from these materials can be reduced to make microwires;
for single microwire only one recording site can be made per
shaft,[173] but for the silicon-based microprobe, thanks to the
novel microfabrication techniques, up to 960 recording sites can
be integrated on a 20 µm thick and 70 µm wide probe.[140] Exploit-
ing boron etch-stop techniques, it is possible to fabricate a silicon
probe shank with the thickness ranging from 5 to 20 µm.[174,175]
In order to prevent mitigate blood vessel damage,[176] as well
as an immune response and neuronal death,[177] the size of
the shank and its delivery aid should be reduced as much as
possible.[178,179] The surgical trauma induced during implanta-
tion should be encouraged to heal, not only through appropriate
surgical techniques, but the minimization of the incision dictat-
ing the scale of the probe itself. Miniaturized features can also in-
crease the number of electrodes per shaft.[180] Importantly, there
is some evidence that miniaturized probes may still prevent an
immune response regardless of the rigidity of the chosen ma-
terial at cellular scale.[181] Neural tissue is very soft with respect
to the materials used for neural probes. For example, the bend-
ing stiffness for a 20–100 µm thick brain slice is estimated to be
10−13 to 10−10 N m per unit width[177] while for a neural probe
made with silicon, this value rises to 10−4 N m. Figure 5 shows
the different bending stiffness for different types of the neural
probes. Using several layers of electrodes is shown to maximize
flexibility in the case of two nanoelectronic thread probes with
cross sections of 1 × 50 µm (inspired by silicon probes) and 1.5 ×
10 µm (based on tetrodes) respectively.[182] Commercial silicon-
based probes (e.g., NeuroNexus) with 15 or 50 µm thickness
are available. It should be noted the thin brittle shanks of these
probes are prone to fracture.[178,179]
The length of the probe shank depends on the target location
in the brain, as well as the species in which the probe will be
implanted. For example, the probes which are implanted into
the hippocampus of rodents are much smaller than those which
have been used for human brain stimulation.[183,184] The main
factor affecting the probe width is the number of required record-
ing sites, which consist of the connections wires and pads.[175]
Therefore, miniaturization of the neural implant is restricted
by the subject species, the number of the recording sites and
the targeted point of the brain. It is also important to note that
as the length of the probe increases relative to its width, it be-
comes less robust, increasing complexity and difficulty during
implantation.[185]
Different neural probes with various forms and materials
have been developed and demonstrated so far for neural activity
recording, stimulation and manipulation purposes. An overview
of these technologies is provided in Figure 6. To decrease the im-
mune response and mitigate the negative effects of micromo-
tion in the brain, a shift away from stiff and needle-like probes
is crucial. The neural device can be made of soft material (e.g.,
polymeric or elastomeric), which provides lower mechanical mis-
match with the surrounding neural tissue than stiff shanks (see
Figure 6B). In some applications, a stretchable neural device is
necessary. Elastic materials, serpentine structures, and mesh-like
neural devices can all be used to achieve this (Figure 6C,E). In this
section, we review the evolutionary trend of the neural probes in
terms of shape and material: from a very stiff needle-like shaft
to soft/stretchable materials and mesh/neuron-like structures. It
should also be noted that despite this remarkable structural trans-
formation and its gains, rigid shanks and needle-like probes such
as Michigan or Utah array are still being used mainly because of
their technological maturity.
4.5. State-of-the-Art Probe Designs
4.5.1. Stiff Probes
A platinum tungsten based tetrode with four probes (diameter of
the metal measuring ≈30 µm) has been widely used to record
neural signals. Electrical potential from 1100 neurons can be
recorded using this probe in the neural tissue.[186] Neural activ-
ity recording using a tetrode in a neurorobotic system, for vari-
ous purposes such as identifying movement-related information
(e.g., in insect and rat), has been successfully demonstrated on
a few occasions.[187,188] The Utah array is widely used in neu-
ral interfaces, and consists of several probes made of stiff ma-
terial, e.g., silicon (see Figure 6A), which record only at the tip
of the shank rather than employing electrodes along the entire
length. Successful applications of the Utah array include neu-
roprosthetic arm control, and motor cortex recording to facili-
tate stimulation of the spinal cord in monkeys,[189,190] as well as
clinical demonstrations for the rehabilitation of tetraplegia.[191]
Restoring hand movements, bypassing the spinal cord circuit,
robot arms and neuromuscular controlling, are all further exam-
ples of the Utah neural probe as used in brain machine inter-
faces. The main drawback of Utah probes and tetrodes is their
unsuitability for deep neural target recording. Michigan probes
consisting of several neural electrodes, and typically with mul-
tiple recording sites along the shank, are versatile devices to be
utilized in brain machine interfaces for different applications.[192]
Compared to the Utah probe, the Michigan probe (with a 3–15
mm long shaft) is better suited to activity recording in deep neu-
ral tissues. For instance, treatments based on stimulation of the
neurons in a rat brain,[193] and restoring missing brain function
have already been demonstrated.[194] The wealth of experience
surrounding Michigan probe fabrication also creates an oppor-
tunity to include other functionalities on the shaft, e.g., LEDs to
create an optoelectrode.[195]
4.5.2. Polymer-Based Probes
Fibers have shown good potential for use in neural devices,
e.g., optical fibers to conduct light into a neural tissue from an
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Figure 6. Evolutionary trend of the neural probe shape and material from very stiff needle-like shaft to soft material-based mesh/neuron-like structures.
A) Stiff shank or needle-like neural probe, B) neural probe with thick fiber and polymer substrate, C) stretchable probe with serpentine metallic structures,
D) ultrathin substrate-based probe, E) ultra-thin polymer-based probe with soft conductive material, and F) mesh-based probe.
outside source (see Figure 6B). A fiber probe has been developed
to simultaneously perform neural signal recording, optical stim-
ulation and delivery of drugs in freely moving mice.[196] Utiliz-
ing this probe, which has been made from polymer using a ther-
mal drawing technique, the authors have carried out neural sig-
nal recording and stimulation for two months. Compared to the
shank or needle-like array probes, polymer-based probes lead to
reduced FBR.[196] Implantable polymer neural probes (Figure 6B)
have also been demonstrated for neural activity recording, stimu-
lation (such as a waveguide made with SU-8 positive photoresist)
and (polyimide-based) fluid delivery in mice.[197] In this work,[197]
a multimodal neural interface prototype enables transfer of elec-
trical signals, fluid, and light for long term applications.
4.5.3. Elastomeric Probes
For some applications (e.g., neural signal recording in the spinal
cord) the probe must withstand local stretching. A soft and
stretchable neural probe has been introduced for chronic neu-
ral signal recording in the CNS.[198] Since the probe has been
made with elastic material, in addition to required static prop-
erties, it meets the demands for dynamic mechanical properties.
PDMS encapsulated optogenetic probes can be used to control
neuronal activities using targeted proteins (see Figure 6C).[199]
The authors concluded that this biocompatible, soft and highly
stretchable device (e.g., 10 times more stretchable compared to
similar probes) enables experiment in various neural tissue in
the body (i.e., peripheral and spinal pain circuits) and for long
term applications.[93]
While a single PDMS encapsulation layer is not sufficient to
prevent moisture ingress, there are many strategies which can be
used to improve its suitability: roller casting instead of spin coat-
ing to prevent defects; multiple thin layers; combining PDMS
with another polymer layer such as parylene to address the prob-
lem of water vapor permeability.[200] In the case of Shelly et al.
the PDMS implant was projected to last five years in vivo, but
only after incorporating a titanium case to protect the electronics
inside.[200,201]
4.5.4. Ultrathin 2D Neural Devices
Ultrathin planes of rigid polymers (e.g., polyimide, parylene, and
polyethylene terephthalate) can be manufactured with the thick-
nesses ranging from 1 to 10 µm (see Figure 6D). Despite their
higher elastic moduli (GPa) with respect to the elastomeric mate-
rial (e.g., PDMS with modulus in the order of MPa), their ultralow
thickness enables a very low bending stiffness. These 2D neural
devices can be applied in cases where the device lies on the sur-
face of the neural tissues, for example in subdural electrocorticog-
raphy. But it should be noted, there are some 2D penetrating neu-
ral probe applications which have also been demonstrated.[202,203]
Electrophysiological signals have been recorded on the surface
of rat brain using an ultrathin parylene-based 2D probe with
the thickness of 4 µm,[204,205] demonstrating that ultrathin flex-
ible and highly biocompatible organic transistor can record low-
amplitude brain activity.
Liquid crystal elastomers (LCEs) are a class of smart materi-
als that reversibly change shape when exposed to a variety of
stimuli, such as heat, light, or solvent. LCEs, as a subclass of
liquid crystal polymers,[206,207] are shape-changing polymers that
possess liquid crystalline order and rubber elasticity. Their low
elastic modulus and large shape change, up to 300–400%,[207]
have made them promising candidates to be used as substrate
for implantable neural devices.[208] The shape change of some
LCEs can be programmed and this feature helps to develop 2D
electronic during the processing and then create a programmed
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3D shape.[209] This feature of LCEs enables the controlled de-
ployment of small recording sites to regions beyond that of the
foreign body response induced tissue encapsulation zone sur-
rounding an implanted shank.[182] LCE’s encouraging history of
biocompatibility, high reliability under harsh working condition,
and low moisture permeability, indicates that they are viable op-
tion for implantable neural devices.[37,210,211]
4.5.5. Mesh-Based Neural Devices
Mesh-based probes are some of the most unconventional de-
signs to have emerged in recent years (Figure 6F). Benefitting
from their extremely low volume and flexible mesh-like struc-
ture, these probes can perfectly blend to the surrounding neu-
ral tissues. One example of direct electrical recording of neu-
ral action potential in rodent brains utilizes subcellular feature
sizes to overcome the and mechanical mismatches and limita-
tions for long term applications.[82] The probe consists of metal
interconnects and recording sites including Pt electrodes and
transistors sandwiched between SU-8 layers with a thickness of
1 µm. The neuron-like electrode (NeuE) mimics the structural
features of the neuron and has been fabricated and applied for
electrophysiology.[179] The NeuE structure comprises metal sand-
wiched between layers of polymer with the total thickness of
0.9 µm. The smallest device polymer and metal widths are 1 and
0.6 µm, respectively.
4.5.6. Mechanically Adaptive Probes
Temporary stiffening of the probe shaft during insertion is al-
most essential for flexible probes with a long, thin shaft, and in
the case of those made from mechanically adaptive materials, the
goal is to produce a probe which does not require any external in-
sertion aid to achieve this rigidity. Two key approaches recruit the
warm, fluidic environment inside the body to alter the composi-
tion of the probe: shape memory polymers (SMPs), with glass
transition temperatures that depend on whether the material is
wet or dry;[212] and nanocomposite polymer matrices, in which
the strong bonds between nanocrystals are broken in the pres-
ence of water.[213]
The Voit group have worked extensively with SMPs, empha-
sizing thiol-ene in their body of work,[214–221] with a specific focus
on the best fabrication practices to prevent delamination and thin
film stress. In one notable example,[222] combining a gold adhe-
sion layer and iridium electrodes with a parylene layer to prevent
moisture ingress, the in vitro study comparing a thiol-ene-based
probe to a fully parylene probe showed significant reduction in
the Young’s modulus (over a factor of 10), and the presence of
immunoglobulin at the implant site.
Nanocomposites of cellulose rods set in a soft, typically bio-
compatible polymer such as poly(vinyl alcohol)[223] (which has
been shown in vivo to produce only mild irritant effects)[224] have
been employed as polymer substrates for intracortical probes.
In the first instance, Jorfi et al. indicate that during chronic
implantation in vivo, the mechanically adaptive composite no-
tably reduces the foreign body response over a time scale of
16 weeks when compared to a stiff probe.[223] The Young’s mod-
ulus reduces by a factor of 40 when soaked in water. Further
to this, a functioning neural probe produced by Hess-Dunning
and Tyler[213] with an even further decreased Young’s modulus
of 10 MPa was used to record single unit activity (SUA) in vivo
for 16 weeks.
5. Encapsulation
The characteristics of polymer substrates and encapsulants are
summarized in Table 3, which highlights the most important
selection criteria. For an in-depth review of materials, with a
view to designing neural probes for permanent implantation,
the reader is also directed to the reviews by Song et al.[225] and
Jeong et al.[226] Many researchers have identified polymer probes
as the future of neural implants; however, special attention must
be paid to biocompatibility testing of each new material, and
application.[227]
5.1. Parylene-C
Parylene-C is a very common encapsulating material, which is
described as flexible (Young’s Modulus 2.76 GPa), and for many
applications, shows encouraging results in biocompatibility tests
(“ISO 10993 USP Class VI biomaterial”).[12] It is an attractive en-
capsulant due to its conformability and biostability,[228] which fa-
cilitates successful in vivo neural recording for a reported max-
imum of 12 months when used as both a substrate and an
encapsulant.[229] It is combined with an encapsulating SU-8 layer
by Seo et al. for acute in vivo recording.[4] Parylene-C is also
transparent which is useful in that the tissue can be easily seen
through the encapsulation material.[4] Alternative applications
for parylene also include the fabrication of transparent electrodes
such as those made using conductive nanowires:[230] parylene-C
offers both flexibility and stability, even in biofluids.[231] Despite
this, it exhibits poor adhesion (either between parylene-C layers,
or parylene-metal) which makes parylene-film devices vulnerable
to moisture ingress during implantation, or delamination during
fabrication due to extended immersion in solvents.[232] Low tem-
perature processing is required to prevent thermal stress in the
polymer, which could cause the final device to be curved.[143,233]
While most traditional nanofabrication techniques are unsuit-
able for parylene-C processing, reactive ion etching is readily
employed, while improved surface adhesion may be achieved
through plasma enhancement.[232,233]
5.2. Polydimethylsiloxane (PDMS)
PDMS is often used to create a microfluidic channel (e.g., for
drug delivery),[234] since it has a high viscoelasticity. PDMS has
been shown to be safe for many existing implantable applica-
tions, the best-known of which includes breast augmentation.
Silicone has undergone significant scrutiny in the decades since
its FDA approval,[235] though biocompatibility testing is a cru-
cial stage in the development of any new neural implant. For
example, the curing agent which is used to solidify PDMS may
be toxic.[236] The immune response evoked by a PDMS implant
may be mitigated using a PAA coating, which through careful
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Table 3. Material properties of the most widely adopted flexible substrate and encapsulation materials including: Young’s modulus, target tissue, fabri-
cation approaches, layer thickness, and transparency. Polyimide often boasts excellent biocompatibility, coupled with simple fabrication requirements
and the lowest single layer thickness. PDMS has a greatly reduced Young’s modulus compared to the other materials.
Material
Young’s modulus
[GPa] Target tissue Fabrication Layer thickness [µm] Transparency Hydrophobicity













40[179] Optically clear[376] High[376]














20[248] Transmittance of 70–80%
in optical range[384]
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0.9[159]–2[256] µm Optically transparent
above 400 nm[389]
Hydrophobic[390]
surface design prevents cells from attaching to the implant.[237]
By increasing the device attraction to water, a hydrophilic coat-
ing reduced the immune response after implantation by regu-
lating protein absorption. During in vivo tests, the PAA coating
curtailed inflammation, with cells unable to cling to the implant.
While the low Young’s modulus of PDMS presents a challenge
in terms of implantation, this remains a positive feature of the
material. Bearing in mind the fact that tissue may recover from
the trauma of a stiff implant if it is promptly removed, a PDMS
substrate would be best paired with a stiff shuttle. Without any re-
quirement on material rigidity, this presents new opportunities
in terms of utilizing ultrathin, flexible ribbon cables, and opening
the structure of the implant, perhaps with a macroporous design.
PDMS is simple to prepare in the lab, and the biocompatibility of
the material may be modulated by changing the ratio of PDMS
elastomer to curing agent or boiling cured PDMS in water prior
to insertion.[238]
5.3. Polyimide
The polyimide group encompasses a range of polymers which,
for the purposes of neural probe fabrication, may be grouped
into photodefinable (suffering from increased water uptake, as
described by Stieglitz)[239] and nonphotodefinable, as a prelimi-
nary classification. While Kapton is one of the most well-known
and widely applicable polyimides, neural probes are commonly
manufactured using PI 2611 (also known as BPDA/PPD and U-
Varnish-S). Despite the fact that polyimides are not FDA (Food
and Drug Administration) approved,[12] they have been evaluated
by researchers at the Lawrence Livermore National Lab using ISO
10993 standards,[142] as well as being USP Class VI compliant.
Testing in water, phosphate buffered saline (PBS),[240] in vitro
assays[239,241] and in vivo studies extending up to 32 weeks,[242]
suggest that polyimides are largely biocompatible for long-term
applications. In order to improve cell adhesion, careful curing at
high temperatures (above 300 °C) in an inert atmosphere evapo-
rates all remaining solvent from the film surface.[241] Polyimides
are a strong choice for an encapsulation material, not least in
terms of their low single layer thickness, which necessitates mul-
tiple rounds of spin coating to achieve a meaningful thickness
above a few micrometers.
They are a popular choice for flexible ribbon cables, employ-
ing: Durimide 7510 for implantation of the sciatic nerve of a
rabbit;[243] PI 2611 which was submerged in PBS at body tem-
perature for one month and evaluated in vitro;[244] U-Varnish-S
implanted into the cortex of Macaque monkeys;[245] and U-
Varnish-S for insertion tests into agar gel.[109] Polyimides are
readily implantable as a substrate material and would be more
likely to withstand insertion force than PDMS. While polyimides
are generally flexible but not stretchable, a novel patterning
method which introduces open slits in the Durimide 7505 film
allows the probe shaft to be stretched by up to 11%.[246] Moving
away from traditional planar probe shapes, a polyimide has also
been utilized by Soscia et al. to produce a 3D array of recording
probes, evaluated for more than one month in vitro, which
provides a flexible alternative to a Utah array.[247]
5.4. Benzocyclobutene
Benzocyclobutene (BCB) is an attractive choice for a flexible sub-
strate. With low water uptake, customarily high biocompatibil-
ity, and reduced layer thickness, dry-etch BCB is an attractive
substrate material. Biological materials may be incorporated on
the probe surface, owing to the properties of BCB. In a notable
example,[248] the focus lies on the fabrication of a BCB neural
probe, followed by evaluation of the thin film. In this case, high
layer uniformity was achieved through rigorous improvement of
the deposition and spinning process. The final thickness of the
probe is quoted as 40 µm. BCB is classified as a substrate in its
infancy, which requires further experiment.[12]
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5.5. Cyclic Olefin Polymer
Cyclic Olefin Polymer (COP) has been employed for microfluidic
applications, offering a reliable seal when the dimensions of
the microchannel features are carefully controlled,[249] and
exhibiting negligible water permeability.[250] An important con-
sideration for COP films is the buckling strength, as highlighted
through experimentation.[151] For a COP probe with a width
of 650 µm, much wider than a typical polymer shaft, the yield
stress increases from ≈8 mN for the 50 µm thickness case, to
around 220 mN for the 200 µm thick film. Although the neural
recording capability was satisfactory, no comment was made on
the longevity of the implant fabricated by Shim et al.[151] Cyclic
olefin copolymers (COC) are a variation on COP, in which the
final polymer is produced from multiple monomers, such that
the material properties may be tuned to include, for example, an
“antioxidant and lubricant,” as produced by Bernard et al. and
evaluated for in vitro cell toxicity.[251] Notable recent examples of
COC neural probes include: the work of Baek et al., comparing
two films with different glass transition temperatures patterned
with an aluminium mold;[252] and a multimodal probe (incorpo-
rating chemical, electrical and optical sensing) using a COC to
form a microfluidic channel.[196]
5.6. Chitosan
With origins in nature, as an increasingly common biomedical
material, chitosan is a pragmatic choice for encapsulation of a
neural probe. It is versatile, employed in hydrogels,[253] med-
ical dressings to help prevent infection,[254] and cancer drug
delivery,[172] to name a few applications. Chitosan is biodissolv-
able but can be mixed with (3-glycidyloxypropyl) trimethoxysilane
(GOPS) to create a nondissolvable coating, or poly(vinyl alcohol)
(PVA) to produce a very strong film. The main focus of some en-
couraging investigation was to successfully show that a chitosan
outer coating would not affect neural recordings and would aid
in identifying the probe during histology.[255]
5.7. SU-8
Many of the neural implants which recruit the negative photore-
sist, SU-8, exploit its flexibility and excellent biocompatibility for
many existing applications. Low cost, easy patterning process and
chemical stability are also important factors to consider. As part of
the iWEBS probe, an SU-8 encapsulation layer was used to facili-
tate smooth insertion of the multielectrode array (MEA) into a slit
in the dura, and promote conformability on the brain surface.[256]
Standard photolithography is an obvious choice for SU-8 pro-
cessing. However, additional fabrication steps may be used to
realize surface patterning, such as nanospheric lithography, or
to create microfluidic channels, such as thermocompression.[257]
Microchannels of SU-8 are also implemented in mm-scale im-
plantable scaffolds which encourage nerve repair.[258] In both
cases, cell interaction with the implant surface is imperative to its
functionality. The roughened, biocompatible surface produced
by Kim et al. showcases significantly increased neuron-like cell
adhesion and growth when compared to an unpatterned SU-8
surface.[259]
Márton et al. performed a definitive in vivo study on SU-8 only
probes (with no electrode metallization) lasting 8 weeks.[260] The
most significant result lies in the radius of the neuronal “kill-
zone,” which for comparative silicon probes reached between 50
and 200 µm. Histological staining around the SU-8 probe re-
vealed no discernible neuronal death only 40 µm from the im-
plantation site, with a glial scar only 5–10 µm thick. Despite sig-
nificant astrogliosis in deep brain layers, the overall conclusion
of their work was that SU-8 is sufficiently biocompatible for their
application.
One notable example takes advantage of the submicron layer
thicknesses of SU-8 to create a wrappable microelectrode array,
which bends around a larger probe to create a nanoelectronic
coating (NEC).[261] Despite the generous size of the gold and plat-
inum electrodes (30 µm × 30 µm), in vivo evaluation of the NEC
facilitated recording of extracellular action potentials from the so-
matosensory cortex of mice.
Possibly the most successful application of an SU-8 substrate,
mesh electronics from the Lieber group have been proven to
elicit no discernible foreign body response even after 12 weeks of
implantation.[159] Combining layers of SU-8 (which total 900 nm
thickness) with gold and platinum metallization on 20 µm wide
polymer “lines,” mesh electronics are thin, conformable, and
incredibly flexible. The longitudinal stiffness is equal to only
0.104 nN m, compared to 3300 nN m for a 500 µm wide poly-
imide film sample.
6. Fabrication
The most common methods of fabrication for micron-scale
neural probes necessitate the use of nanofabrication facilities,
employing techniques such as photolithography, thin film depo-
sition, and various etching styles, among others.[262] There are
incredibly high standards imposed on medical implants before
they are deemed safe for use in human tissue.[185] As such, there
is an emphasis on manufacturing techniques which will prevent
device failure and ensure the longevity of the implant. This report
provides a brief explanation of the nanofabrication techniques
implemented in neural implants, as shown in Figure 7.
6.1. Nanofabrication Methodology
When considering flexible polymer probes, often the first step
is to deposit or solidify the substrate layer. This is often accom-
plished using spin coating and baking. Thin film deposition is a
general term which refers to techniques including, but not lim-
ited to, chemical vapor deposition (CVD), which is an important
step in the encapsulation of implantable devices in parylene-C.
Increasingly miniaturized transistors necessitate films which are
typically 5 nm thick, reduced to the point where the results of
CVD are not always repeatable.[263]
To create the electrodes, tracks, and contact pads, evaporation
or sputter deposition is employed: this is a form of physical vapor
deposition from which electrodes are detailed after lift-off.[109,264]
Interestingly, patterning may be achieved through microcasting:
this generates features with micron-scale dimensions.[265] Wet
etching allows for the removal of polymer layers, useful when
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Figure 7. Various fabrication methods are explained above: A) wet etching, B) adhesive bonding, C) microcasting, D) thin film deposition, E) sputter
deposition, F) blade dicing, G) transfer printing of micro-LEDs (redrawn from[332]), H) simple fabrication using thermal lamination of gold on COP
(redrawn from[151]), and I) traditional photolithography with gold deposition on polyimide.
exposing the electrodes so that they may make contact with the
target tissue. This is also known as isotropic etching,[266] and
uses liquid chemicals to remove material; in dry-etch processes,
wafers are bombarded with ions to the same effect.[109,264] Ad-
hesive bonding may be employed when there are several lay-
ers of polymer which must be bonded together and sealed. This
technique improves the likelihood of the implant being biocom-
patible, and comprises of the adhesive hardening or solidify-
ing to join together two surfaces, possibly using heat to facili-
tate the reaction.[267] The increased time and expense required
for adhesive bonding is offset by increased joint stiffness, fa-
tigue strength, and the variety of materials which may be bonded
together.[268]
When using silicon as a probe substrate, there must be some
method of shaping a wafer into a thin probe shaft. Wafer dic-
ing often produces fragile chips, typically with defects;[185] despite
this, it is employed as a simple and repeatable approach to achieve
the probe shape. If the probe is especially long, with a reduced
width, care must be taken to ensure the wafer does not have any
defects which could cause fracture during implantation.
Transfer printing allows for stiff electronics to be fabricated
first on a traditional substrate, and then transplanted to a more
suitable (flexible, polymeric) substrate: this prevents any dam-
age to the receiver substrate which is not well suited to nanofab-
rication techniques.[269] Nanoscale manipulation has also been
made possible through transfer printing techniques, with pre-
cision largely unmatched by techniques such as optoelectronic
tweezers. PDMS ‘𝜇-stamp[s]’ have been used to arrange nanowire
lasers with a precision in the nanometer range.[202] Interest-
ingly, transfer printing appears to be a powerful and transferable
method of manipulating micron scale electronics, allowing for
independent manufacture of the component part required for a
neural probe.
6.2. Successful Fabrication Protocols
Neural probes are typically produced in a cleanroom environ-
ment, and these traditional, relatively inexpensive techniques
may be used to produce increased electrode areas:[270] 50 ×
50 µm2 recording electrodes, and a shaft width of 525 µm. First,
the silicon substrate was spin-coated with photoresist, which was
then exposed to ultraviolet (UV) light through a mask and devel-
oped. An adhesion promoting layer of titanium was deposited
using e-beam, followed by sputter deposition of platinum to cre-
ate the electrodes and connections. A second photolithography
routine was carried out, with the addition of blade dicing in be-
tween the UV exposure and developing; the photoresist acts as a
protective layer during dicing. Finally, silicon nitride was sput-
tered onto the device for encapsulation purposes. A range of
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Figure 8. A) Syringe injectable mesh electronics. B) Microchannel in flexible probe filled with fluid to provide stiffness. C) Rigid shuttle and miniaturized
probe with ribbon cable attached. D) Flexible probe coated in a biocompatible dissolvable material.
testing showed that for even the smallest fabricated electrode,
when the photolithography process was successful, the final
impedance aligned with recommended impedances for neural
probes.[271]
While parylene-C is a common choice for polymer probes, the
soft substrate can also be combined with a number of other tech-
niques to improve the robustness and performance of the neural
probe. A parylene substrate may be coated with a PVA/Poly(lactic-
co-glycolic) acid (PVA/PLGA) mixture to provide the necessary
strength for insertion.[272] Notably, in the final fabrication step the
device was spin coated with PEDOT:PSS, which is a conductive
solution, before the top sacrificial layer of parylene was removed
such that only the electrodes were coated. This served to decrease
the impedance and increase the SNR.
Prioritizing simple fabrication, films of COP may be thermally
pressed and laser machined to provide layers of substrate and
encapsulation, as well as a desired probe shape.[151] COP acts
as a substrate for gold stimulation electrodes without the use
of cleanroom photolithography. The miniaturization process was
aided by UV laser machining, in which a laser with a reduced
beamwidth yields smaller features. Gold was thermally lami-
nated onto a COP substrate, which was covered over with a sec-
ond COP encapsulation layer after the gold layer had been ma-
chined, leaving electrodes and connective lines behind. A CO2
laser was used to cut through the COP top layer and expose ar-
eas of interest on the conductor: mainly, the electrodes at the tip
of the shaft and connections at the top. In the case of the COP
thermally laminated probe, the minimum width was not compa-
rable to mesh electronics, or even the state of the art in traditional
probe shafts. This technique lacks the precision required to suc-
cessfully target and record single unit potentials.
7. Implantation
The method of implantation is dictated by the characteristics of
the neural probe. While stiff probes require simpler surgeries, re-
cent emphasis on flexible probes means that alternative implan-
tation methods must be explored. Each mechanism of implanta-
tion is illustrated in Figure 8, and it is clear that they each hold
merit.
7.1. Surgical Techniques
With the great aspiration of implanting neural microelectrodes,
stereotactic neurosurgery is a procedure commonly employed by
neurosurgeons to find the finest strategies to reach the area of
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interest within the brain, minimizing any potential risks for vi-
tal structures. It commonly requires the use of advanced imag-
ing techniques. The generation of high-resolution 3D imaging
data, to ensure the safe insertion of neural device according to a
specific 3D coordinate system have been widely studied in ani-
mal models. In vivo imaging techniques, such as two-photon mi-
croscopy is explored as a promising tool to provide 2D and 3D
reconstruction of neurovascular networks with a subcellular res-
olution and allow the study of tissues responses as consequences
of neural probe implantation.[273] Moreover, this procedure is im-
portant to find the best routes for the target area and reduce
vascular intracerebral edema that may lead to neuroinflamma-
tory response and electrode defeat.[273] Nowadays, there are still
some limitations in using this technique for human brain surgi-
cal planning, and noninvasive neuroimaging methods, such as
functional magnetic resonance imaging (fMRI), are commonly
applied for specific epilepsy and tumor surgeries.[274] Interest-
ingly, the usefulness of real-time two-photon image recording has
been recently demonstrated in living human ocular tissues, rep-
resenting a great opportunity for in vivo neurological investiga-
tion in future.[275]
Among different surgery techniques, very significant is the de-
velopment of computer-driven system, such as robotic technol-
ogy for stereotactic neurosurgery which provides the surgeon a
high-precision manipulation system, minimally invasive and ac-
curate stereotactic approaches, and image-guided procedures, re-
ducing the risk of human errors and operating time.[276]
A very recent progress in the area of brain-computer interface
technology is the development of the so-called “sewing machine”
for the brain. The major goal of this research is the fine implan-
tation of miniaturized flexible neuromorphic devices with min-
imal invasive tissues damage. The first application of this new
approach was performed implanting recording electrodes in rat
somatosensory cortex but further studies are needed to confirm
its possible clinical application.[277] Due to the very novel nature
of this technology, Hanson et al. are yet to publish their work in
a peer reviewed journal. Nevertheless, sewing machine approach
will open the door to major knowledge of brain tissue and, in the
near future, to the treatment of neurological conditions.
7.2. Insertion Forces
Compliant flexible neural probes exhibit higher mechanical com-
pliance, and they show promise in enhancing the long-term per-
formance, comparing to traditionally stiff and needle-like neu-
ral probes.[41,278–280] However, the main disadvantage of flexible
designs is their challenging insertion procedure, for which nu-
merous overcoming techniques have been proposed and demon-
strated by different groups. Reliability of insertion is a major is-
sue for flexible probes, and because of their much lower Young’s
Modulus than silicon-based probes (e.g., Utah Array and Michi-
gan), they are less stiff and less able to pierce the brain tissue.
Yielding/bending, rapture and buckling are mechanical fail-
ures that can occur during insertion. Buckling failure is more
dependent on the probe geometry, while rapture and yield fail-
ures mainly depend on material properties.[281] Critical buckling
load (force) is important, because in practice, it can prevent in-
sertion misalignment, breakage or tissue fracturing.[100] There-
fore, a precise and successful insertion requires a quantitative
analysis of design parameters, such as probe shank parameter,
length, and tip size/shape. Always there is a tradeoff between crit-
ical buckling force and probe shank diameter, i.e., thinner shanks
are more susceptible to buckling failure because of their smaller
critical buckling load. The insertion method, in which insertion
speed and angle are varied, has a significant impact on the suc-
cess rate. In the case of a thin silicon probe, altering the insertion
protocol (reduced speed and increased insertion angle compared
to the perpendicular) reduced the insertion force by a factor of
six.[282]
In different studies on rat brain, insertion forces through the
pia matter have been measured to be 0.5–2 mN, using different
probe geometries and material.[283,284] Probe shank tip shape, size
and sharpness can highly affect insertion force. Studies show that
probe tips with opening angles of <20° can penetrate dura with-
out dimpling, but for probe tips with opening angle of >40° dif-
ficult dura penetration has been experienced.[285,286] Various ta-
pered probes have been investigated and pia penetration forces
of 0.48–1.15 mN have been reported for different tip opening an-
gles and shank diameter.[283]
7.3. Stiff Probes Implantation
One of the most well-known neural probe design projects was
undertaken in 1981 at Michigan University: the silicon-based de-
sign which is now known as the Michigan probe. At its tip, a
Michigan probe may be only 20 µm wide.[287] While the rigid-
ity of the probe would surely generate an immune response and
further damage during micromotion, the silicon shaft is noted
as being strong enough to pierce the dura mater. In an attempt
to compromise between flexibility and precision, a rigid silicon
probe can be combined with a flexible ribbon cable: this makes
for an essentially “floating” probe which is not adversely affected
by micromotions or connections to the skull.[288] While an im-
mune response will still be invoked by the stiff probe, in which
encapsulation will increase the electrode impedance, it has been
reported that recording is still possible after a number of weeks.
7.4. Shuttle
The specifics of neural probe insertion using a shuttle or inser-
tion rod[289] first involve the preparation of the skull, dura mater
and pia mater. Once a burr hole has been made, the flexible probe
is pushed down into the brain tissue, wrapping around the shut-
tle as it goes. When the insertion rod is removed, the flexible
probe remains in place. Although this allows for the very pre-
cise placement of the probe, there are a number of disadvan-
tages to consider: the removal of the shuttle causes further sur-
gical trauma;[272] an implantation lesion and further glial layer
may be observed; and the surgery itself requires careful han-
dling. A sharpened shuttle would be capable of piercing the dura
mater and delivering probe arrays to the intended position in the
brain.[161] Maintaining the integrity of the dura mater is impor-
tant for preventing inflammation and bleeding. After sharpening
the tip of the shuttle in all three dimensions, and successfully im-
planting a probe through the dura, SUA has been recorded for
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95 days. The use of nontraditional shuttles resulted in reduced
bleeding during implantation and low insertion force,[182] which
is also impacted by the topography and size of the probe, as illus-
trated using microthread electrodes.[290] Shuttle design will take
cues from the most successful rigid probes, exploiting the best
aspects of a rigid, temporary component and a flexible, chroni-
cally implanted probe.
7.5. Biodissolvable Coating
In order to temporarily stiffen a flexible probe, various biore-
sorbable coatings are explored in terms of their rigidity, biocom-
patibility, and time required for dissolution. Bioactive or biofunc-
tionalized coatings have been discussed in Section 3.6. However,
such a coating may also contribute to the mechanical character-
istics of the probe in the short term. There are several benefits to
a hybrid PVA/PLGA hybrid coating:[272] both of these polymers
have their individual advantages, although both are biodissolv-
able and often biocompatible. In Pas et al.,[272] the body of the
probe was coated with PVA, while the tip was coated with PLGA.
The pairing of the readily dissolvable PVA with the hardier PLGA
allows a sharp probe tip to be maintained throughout surgery and
beyond if required. Silk is another example of an organic poly-
mer which is incredibly strong and ordinarily biocompatible.[291]
Polyethylene glycol (PEG), which begins to degrade within min-
utes of insertion, is often used to stiffen the probe shaft.[233] It
has been certified as food-safe by the FDA,[292] and deemed bio-
compatible for medicine delivery in the central nervous system,
with the immune response around the PEG hydrogel limited to
a 50 µm radius.[293]
7.6. Microchannel
Microchannels in neural probes may be filled with stiff materials
during insertion,[294] which are removed once the probe is im-
planted, such that only the flexible probe remains. One such ma-
terial is PEG, which is used as a base for many hydrogels. The
microchannel may also be used for drug delivery after implanta-
tion, in order to mitigate the inflammatory response which pro-
hibits chronic implantation.[295] During recording, when flexibil-
ity is paramount, the channel could be filled with water.
7.7. Syringe
Since mesh electronics may be implanted using a syringe with
diameter < 100 µm, trauma is reduced during initial inser-
tion. However, since the mesh “unrolls and expands,” this tech-
nique lacks the precision of more traditional, larger, shuttles or
rigid probes. When mesh electronics are compared to thin film
electronics,[296] the latter are not readily injectable, even with re-
duced dimensions compared to mesh electronics. There can be
no doubt that the competing stiffness requirements of a neural
probe during insertion and chronic implantation cannot be met
without a hybrid approach. In the ideal case, the implantation
mechanism is stiff, and the chronically implanted probe is soft
and flexible. While the syringe used to implant mesh electronics
appear to solve this problem, the syringe is a niche method which
is only applicable to a fine mesh: even thin film electronics can-
not be successfully implanted. Most notably, the syringe has the
option of piercing the dura mater without further surgical trauma
involved in trepanning and removal of the dura.
While mesh electronics are best suited to insertion via sy-
ringe, the novel Injectrode from Trevathan et al. is designed in
such a way that the electrode is inextricable from its implanta-
tion method.[297] Silver particles embedded in an uncured sili-
cone elastomer matrix are injected around a nerve to cure inside
the body, allowing the electrode to conform precisely to its target
tissue. This innovative design is defined by the minimal inva-
siveness of the surgery. Once cured, the Injectrode has a Young’s
modulus of only 72.1 kPa, and as such significantly reduces the
mechanical mismatch between probe and tissue.
7.8. Alternative and Custom Insertion Methods
The insertion methods discussed previously represent some of
the most common techniques; however, lesser-used methods
have their own unique benefits. Two notable works involve us-
ing a metal rod or needle as temporary insertion aids, without
adhering the polymer probe along the length of the rod.
By etching a hole into the tip of a polyimide probe, Zhang
et al. created a simple system in which a needle could be threaded
through this hole and adhered with a small amount of PEG.[298]
This could then be used to insert the polyimide probe before the
PEG dissolved in the brain, after which the needle could be re-
moved. After in vivo evaluation of this technique, local field po-
tentials could be recorded from the CA3 region of the rat hip-
pocampus for at least seven days.
Successful in vivo implantation was carried out by Richter
et al.[289] The inserted polyimide probe measured 20 µm ×
350 µm × 1.5 cm and after the skull of the rat was opened, the
flexible probe could be placed flat onto an “agarose cushion.” At
this point, a tungsten rod was placed at the midpoint of the poly-
imide probe, and used to push the flexible shaft down into the
brain tissue. After seven days, only a “mild tissue reaction” was
observed.
Similarly, an insertion guide which is placed on the brain sur-
face is employed to reduce the decrease the effective length of the
probe.[299] Fabricated using poly(methyl methacrylate) (PMMA),
the insertion guide increased the maximum force which could
be applied to the probe (before buckling) by more than a factor
of 3. This was tested in vivo, with a 100% insertion rate when
employing the guide versus only 38% success without.
PEG has also been employed to temporarily shorten the length
of the flexible probe shaft,[300] when poured over the top half (in
the length direction) and cured. As such, the buckling force was
measured in a brain phantom, and was significantly improved to
2.14 mN for a braced probe.
8. Energy Transfer and Harvesting
Wireless power transfer is an ideal approach to provide contin-
uous power to the implant, especially when the power transfer
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or harvesting systems are miniaturized or biocompatible. Con-
sequences of conventional powering techniques are numerous,
beginning from the negative effects of repeated surgeries,[301]
severe foreign body response,[12,13] or even temperature issues
surrounding the battery as an effect of the power consumption.
Through the use of wireless power transmission techniques, the
long-term viability of the implant is improved enormously, in
terms of integration with the brain tissue reducing the adverse
response of the tissue against the materials and big shapes that
commonly are used in battery-based architectures. For that rea-
son, this is the most common choice in the design of novel
bioimplantable devices, and in particular, for brain stimulation
as reported by other authors.[59,105,302] Besides, wired power and
data transfer requires “tether[ing]” of the test subject to an exter-
nal device, which will induce micromotions.[303] Requirements
for stimulation and recording are different in terms of device
design.[59,105,302] While for stimulation the main design constraint
is focused on preventing any brain tissue damage; in neural
recording, the main limitation is the apparent recording site
impedance which changes over time as a result of the cellular
growth of brain tissue around the neural probe. This increas-
ing number of cells around the neural probe affect the efficiency
and the quality of the neural recordings as an effect of a higher
impedance that reduces how the signals are recorded. These sorts
of limitations must be taken into consideration in the design
phase and during implantation period since the voltage require-
ments vary with the time. Communication limitations and im-
plant size restrictions are not generally dependent on stimulation
or recording architectures.
Despite focusing on the benefits of wireless power for im-
plantable devices, it is important to briefly mention the aspects
of wired devices which may impede the natural movement of test
animals, or perhaps dictate the design of the probe as it connects
outside the skull. Headstages are employed both in wireless and
wired systems, although a wired system must also include an
external connector. Incorporating recording electronics and sig-
nal enhancement,[304] Limnuson et al. combine a straightforward
wired design with a rotating commutator to allow for rats to move
unimpeded. The headstage may also be used to protect the im-
plant inside a rodent brain, preventing trauma which will dam-
age the neural probe and the rodent itself: alleviating this risk
means that rats may be pair-housed in a more natural, stimulat-
ing environment.[305]
The final component of the implantable system is the con-
nector which allows a cable to interface with an external com-
puter. Three common options for these connectors include
zero insertion force (ZIF) connectors,[177,306,307] which may be
combined with polymer probes; or rigid alternatives such as
Omnetics[110,233] or Samtec[308,309] connectors.
The miniaturization of recording electronics, combined with
light and potentially flexible wireless power transfer systems,
mean that the future of implantable probes lies in completely un-
tethered implants.
However, a key challenge lies in the miniaturization of the
system:[301] without a reduced implant size, power transfer may
only be realized through a thin layer of tissue. Advancements in
various types of technologies for power transfer (ultrasonic and
electromagnetic) and energy harvesting (photovoltaic, thermo-
electric, triboelectric) are discussed below in detail, as illustrated
in Figure 9. The characteristics of these power transfer systems
are highlighted in Table 4.
8.1. Ultrasound
While electromagnetic coupling may be used to power medical
implants, relatively long wavelengths and high losses within the
body mean that ultrasound is a contender for a more efficient,
miniaturized, wireless power transfer system. The benefits of ul-
trasonic systems are identified in terms of their compatibility
with human tissue.[310] First, the safe exposure level for ultra-
sonic power is significantly higher than that of radio frequency
(ultrasonic, 720 mW cm−1 and radio frequency (RF) 10 mW cm−1,
respectively), while the power losses associated with ultrasonic
transmission through tissue are comparatively lower than RF
losses.
Frequency is an important issue in implantable wireless de-
vices: acoustic waves have much lower velocity compared to elec-
tromagnetic waves,[311] with wavelengths in the order of mil-
limeters, and low frequencies. As such, ultrasonically powered
systems may be miniaturized further than the antennas re-
quired for electromagnetic transfer, without compromising on
efficiency.[312] The importance of miniaturized device footprint is
highlighted through the careful development of a 0.8 mm3 neural
implant. Ultrasonic power is also not so dependent on the align-
ment of the device, compared to the alignment of antennas in an
electromagnetic system; this will make for more uniform power
delivery between patients.
A standout technology utilizing ultrasound power transfer for
both EMG and EEG recording is neural dust, which can also
perform wireless communication with a “vanishingly small”[313]
piezocrystal implant and external Bluetooth module. Seo et al.
have published a well-rounded body of work on their neu-
ral dust technology, from MATLAB simulations[314] to in vivo
validation[315] and a wearable system for untethered rodent
experiments.[316]
8.2. Electromagnetic
Electromagnetic wireless power transfer relies on the resonance
phenomenon. It makes use of two antennas, defined as conduc-
tive structures that are resonant at a certain frequency. There are
different shapes, geometries and materials where the antennas
can be implemented. Since size matters for bioimplantable de-
vices, higher frequencies are often chosen, reducing the sizes of
the antennas. However, receiver and transmitter antennas can
be in different geometries if and only if they are resonant at the
same frequency. The electromagnetic wave goes through the tis-
sue from transmitter to receiver antenna. Depending on the dis-
tance from the two antennas, the typologies are named near-field,
mid-field, or far-field and they present different characteristics
and limitations.
Some of the difficulties introduced by near-field coupling in-
clude the fact that brain tissue is lossy, near-field transfer un-
dergoes exponential decay, and there is weak coupling between
transmit and receive coils when they are not properly aligned.[59]
Despite this, innovative antenna design yields reduced footprints
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Figure 9. A) Piezoelectric energy harvester. B) Flexible subdermal solar cell. C) Far-field electromagnetic coupling. D) Mid-field electromagnetic coupling.
E) Near-field electromagnetic coupling. F) Triboelectric energy harvester. G) Thermoelectric energy harvester. A–E) Adapted.[303] F) Adapted.[368] G)
Adapted.[326]
and high efficiency: for example, successful antenna designs may
have an antenna diameter of less than 1 mm.[317]
Mid-field coupling is used to construct a power transfer sys-
tem which would be equally effective no matter where it was
implanted in the body.[59] The whole device prepared for implan-
tation was only 2 mm in diameter and 3.5 mm in height and can
deliver 195 µW to the heart and 200 µW to the brain when the
source output is 500 mW. The most favorable regime is mid-field
for power transfer, due to the observed efficiency at the selected
ideal frequency ( 1
d3
), where in this case d refers to the distance
between transmit and receive antennas.[318]
The far-field approach has several benefits: most notably, the
reduced coil diameter with increased operational frequency. A
3 × 3 mm antenna operating in the far-field is capable of pow-
ering an implant at a distance of 20 cm.[39] While the increased
losses associated with far-field power transfer may be compen-
sated by increasing the transmitted power,[301] any solution must
take into account specific absorption rate (SAR) limits for safe
operation.[39,318]
Electromagnetic wireless power transmission techniques are
not exempt from risk. One of the most studied influences of elec-
tromagnetic waves on the human tissue is the SAR which was
addressed before. However, this issue can be relatively easy to
control as it depends on physical parameters that can be mod-
elled.
8.3. Photovoltaic
Implanted solar cells are smaller, lighter, and more flexible than
battery implants. These absorb light in the near-infrared and
visible regions, incident on the cell even through layers of hu-
man skin. Cells may absorb both natural and artificial light,
illustrating the success of photovoltaic cells for low-powered
implants.[319] In general, the power generated by a solar cell
during everyday activities is sufficient to power a pacemaker,
without any particular efforts made to increase the light inci-
dent on the implant. Existing implanted solar cells are typically
made from silicon, which have been reported to generate over
600 µW of power.[320] However, its stiffness causes damage to
the surrounding tissues and skin. Two challenges presented by
solar implants are the need for thin, flexible cells, as well as
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Table 4. Characteristics of wireless power transfer and energy harvesting technologies. The most important aspect of such a system involves balancing




length Experiment type Flexibility Size Reference
Ultrasonic Harvests maximum of
5 Vpp





Encapsulated with PDMS N/A Tested in water Yes 16 elements
measuring 1 mm




2.4 V × 156 µA N/A N/A Ex vivo Flexible PCB
and polymer
layers
4 cm × 4 cm [393]
Electromagnetic Coupling 500 mW, receives
200 µW in the brain
Far below SAR limit for 500 mW
coupling






Electromagnetic 19 mW Planned for future work N/A Computer Model,
Phantom
No 0.9 mm3 [317]
Photovoltaic 90 µW minimum Planned for future research 34 min Ex vivo Yes 64 × 37 mm [394]





Photovoltaic 60 µW Yes, tested in vitro 3 days In vivo N/A 390 µm × 410 µm ×
1.5 µm
[395]
Triboelectric 4 V Encapsulated with PVA or PLGA 9 weeks In vivo Yes, polymer-
based
2 × 3 cm [322]
Thermoelectric 645 µW Biocompatible insulator used 20 min In vivo N/A Surface area
0.83 cm2
[329]
Thermoelectric 25 mV Requires encapsulation >260 s In vitro, in vivo No 10 mm × 10 mm ×
3.9 mm
[325]
improved biocompatibility of the cell substrate to remove further
encapsulation.[312,320] Alternatively, bioinert and bendable encap-
sulation materials such as those used for neural probes are also
effective.
8.4. Triboelectric
The triboelectric effect, which converts biomechanical energy
into useable electrical energy, has been employed to power wear-
ables on the surface of the skin,[107] and more recently, it has
been explored as a power harvesting method for biomedical
implants.[321] Using materials such as PLGA (see Section 7.3,
Biodissolvable Coating),[272] patterned layers of polymer create
frictional surfaces. When these layers are forced together and
then detached, this induces a voltage which can be used by
to stimulate cells. A stimulator may be made using familiar
materials[322] such as PDMS and polyimide. PDMS has also been
used as a patterned layer in conjunction with an ionogel[323] to
create a biocompatible and conformable device, with a footprint
of 3 cm2 and a thickness of 1.2 mm. Movement on the surface
of the skin, or even on cardiac tissue, is rarely sufficient to power
a neural implant. Coupling a triboelectric energy harvester with
external ultrasound transmission[311] to create a “vibrating and
implantable triboelectric generator (VI-TEG),” it is possible to
charge a battery of the sort implanted alongside a pacemaker.
8.5. Thermoelectric
The low efficiency of thermoelectric generators (TEGs) is off-
set by their high reliability, which is crucial in chronic implan-
tation cases. µ-TEGs have been used to power biomedical elec-
tronics for the heart, ears, and brain,[324] with dimensions in
the order of 1 cm. The temperature differential between the
human tissue and the device generates a current in the ele-
ments of a TEG, which is ideally placed close to the skin. Us-
ing a sample of porcine skin and fat, a 3.3 mV output was
achieved with an implanted TEG. This was subsequently im-
proved by cooling the skin to increase the gradient between
the core and surface temperatures of the body, which provided
an output voltage of 6 mV.[325] Flexible materials have been ex-
plored for wearable TEGs,[326] since improved conformability
to the heat surface will also improve the heat transfer capabil-
ity of the device. Once such flexible material is PEDOT:PSS,
which boasts excellent biocompatibility,[327] and so would be suit-
able for implantable TEG applications. It has also been sug-
gested that the device is placed close to an artery, for example
the carotid artery. Through natural heat loss mechanisms, up
to 32.3 W of heat is lost there, although this is dependent on
the flow rate as the carotid supplies the brain.[328] During in
vivo testing in a rat brain, careful design of a lightweight TEG,
with a surface area less than 1 cm2 reportedly yields 645 µW of
power.[329]
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9. Design Recommendations
While the key aspects of neural implant design have been dis-
cussed in this progress report, it is important to summarize the
conditions in which a device is most likely to succeed. Although
previous research has yielded guidelines for the ideal implant,
limitations in fabrication, surgical insertion, and material science
are only some of the challenges which must be overcome to reach
this specification.
9.1. Mechanical Flexibility
As highlighted in Section 4, the closer the Young’s modulus of the
shaft material to brain tissue, the more successfully the implant
integrates with the host tissue: rigid substrates such as silicon
are likely to cause increased damage during chronic implanta-
tion due to micromotion. With the aim of encouraging neuronal
growth, the substrate should be as flexible as possible: neurons
can grow three times the number of branches[94] when adhered to
a soft substrate when compared to a rigid one. A flexible substrate
acts to reduce the interfacial force on the implant,[182] preferably
until it is equivalent to the forces which occur during natural pro-
cesses such as inflammation and the growth of blood vessels.[330]
Despite the importance of substrate flexibility, there is a limit to
the efficacy of polymer probes, when no other techniques are em-
ployed to improve the chronic implantation case. When compar-
ing silicon with polyimide and off-stoichiometry thiol-enes-epoxy
(OSTE+), the FBR is greatly reduced in the case of polyimide ver-
sus silicon. However, while OSTE+ has a much lower Young’s
modulus even than polyimide (6 MPa vs 1.5 GPa), the presence
of immune markers is not significantly changed by the use of
OSTE+.[63]
9.2. Stretchability
On the theme of micromotion and tissue damage, the selected
substrate should be stretchable to accommodate for any force in-
cident on it, and the motion involved in free movement of the
host, breathing, or the changes associated with blood flow. Re-
ported values for micromotion vary; however, micromotion of at
least 30 µm should be expected for brain tissue.[97] Various meth-
ods for increasing the stretchability of the probe include creating
slits in the polymer substrate,[246] the addition of a plasticizer,[327]
or patterning a prestrained polymer to ensure the metallic tracks
remain unbroken even after the substrate is stretched to twice its
original length.[331] Silicon substrates are ubiquitous in the fabri-
cation of micron- and nanoscale devices, with extensively devel-
oped protocols; on the other hand, devices are not routinely fabri-
cated on a flexible substrate, instead diced and etched for transfer
between the original rigid substrate and the polymer layer. Spe-
cialized techniques such as transfer printing[332] are integral to
this multistage process.
The key difference between substrates such as polyimide ver-
sus PDMS is that while both exhibit flexibility, the stretchability
of PDMS is inherent, whereas polyimide can be made stretchable
through techniques such as kirigami.[333] Both characteristics are
key to biomimetic electronics. However, stretchable electronics
are viewed as a further development towards truly conformable
devices and circuits, and a “significant departure”[334] from
their solely flexible counterparts. When adhered to the skin, for
example, a flexible substrate cannot wrinkle naturally as skin
would:[335] a stretchable substrate conforms completely to the
surface it is adhered to. Finally, stretchable electronics are better
suited to rounded surfaces when compared to simply flexible
electronics.[336]
9.3. Miniaturization and Scalability
The neural implant topologies which are most successful at pre-
venting prolonged immune response are miniaturized such that
the feature size is of the order of the target cells.[182] For example,
mesh electronics successfully avoid invoking immune action,
and were designed with “cellular or subcellular dimensions.”[337]
Standard photolithography is generally used for feature sizes
greater than 1 µm; however, novel PDMS mask molds have il-
lustrated features of the order of hundreds of nanometers.[338]
Electron-beam lithography, which is both more expensive and
time consuming, has nevertheless been reported to yield features
smaller than 4 nm with great effort.[339]
9.4. Untethered
Typically, an implantable probe shaft will either be connected to a
platform which incorporates electronics necessary for recording
and stimulation or will be connected for wired communication.
This contributes to tissue damage during chronic implantation:
specifically, increased scarring and breach in the BBB.[340] When
comparing a floating electrode with one which is connected by
wire, sealed with elastomer and linked to a connector secured to
the skull, there is obvious benefit to the untethered electrode. The
immune response was not merely increased in the tethered elec-
trode: up to four weeks after implantation, the response to the
secured electrode worsened, while the tissue around the floating
electrode began to heal.[103] The mechanism by which the elec-
trode is anchored will impact the FBR, but not the density of
neurons.[341] During animal experiments, “physical tethers” will
hamper natural behavior:[105] this is significant when researching
the neurological effects of an implant, rather than merely the im-
munological effects. It is important to note that wireless commu-
nication and power, while removing the need for bulky tethers,
will in turn necessitate electronics for, e.g., rectification, voltage
regulation and tuning.[342]
9.5. Biocompatibility
Section 4 highlights the characteristics which must be consid-
ered when choosing a polymer: chief among these is biocom-
patibility. This term denotes materials which have negligible
negative effects on the body, and may also encourage tissue
performance.[343] While traditional neural probes allow the elec-
trode tracks to be exposed to brain tissue, both synthetic and or-
ganic polymer encapsulation is used in modern probes to prevent
corrosion and cytotoxicity. Implantable metals such as platinum
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or gold should be encapsulated when possible, and only exposed
when contact is required for recording or stimulation. Probe fail-
ure, including delamination, should be prevented to mitigate tox-
icity to cells.
9.6. Open Volume
A macroporous,[337] open design encourages neuronal penetra-
tion and successful integration of the implanted device. De-
creased surface area helps to mitigate immune cell activation,
damage to the BBB, and tissue death.[87] It is important to note
that even when compared to a shaft with identical dimensions,
the volume of tissue surrounding the open implant showed
marked improvement in tissue penetration. Material scaffolds
in the field of neural implants are inspired by the ECM, which
is a 3D mesh structure comprised of nanometer-scale protein
fibers.[116] Mesh electronics, at the single-micron scale, promote
cell growth.
9.7. Reduced Impedance
Single unit activity recording requires both increased specificity,
and decreased impedance.[344] When incorporated with a “neu-
rosensing system” the impedance of the probe must be carefully
matched to the system to prevent electrical losses.[345] Efforts may
be made to reduce the electrode impedance, at the expense of the
surface area, or by selecting conductors with lower impedance
for the same surface area. Avenues to increase the electrode sur-
face area without sacrificing the probe footprint include creating
trenches, exposing more of the metal when compared to a flat,
flawless surface.[346] Alternatively, coatings such as PEDOT:PSS
may be used to reduce electrode impedance by up to a factor of
10.[347] Electrodeposited platinum-iridium coating also serves to
decrease the impedance of microelectrodes by a factor of 5, and
improve the SNR.[345,348]
9.8. Temperature
Electronic stimulation of neural tissue is accompanied by a
change in temperature, much in the same way brain regions em-
ployed during natural behavior will also undergo a temperature
increase. This is due to the dissipation of certain amount of elec-
trical power, and the rise temperature over a safe threshold may
be harmful for the tissue function. A maximum increase of 1 °C
is acceptable when seeking to prevent tissue damage.[44] This is a
particulate concern for optogenetic stimulation, which requires
the use of LEDs. Unsurprisingly, the temperature increase is cor-
related to the root mean square (RMS) of the stimulation voltage
during DBS.[349] Aside from temperature issues during normal
operation, patients are at risk during MRI scans,[350] which may
be necessary at some point in their treatment for neurological dis-
orders. Several steps should be taken by clinicians to remove risk
to the patient: the use of a transmit-head-receive coil, switching
the stimulator amplitude to zero, and switching it off.[351]
From a surgical standpoint, extensive review and experiment
from Shoffstall et al.[352] indicates that the temperature increases
in brain tissue caused by drilling during craniotomy is significant
enough in a rat brain that it will impact the neuroinflammatory
response. Their findings indicate that saline irrigation is insuffi-
cient to prevent an increase in BBB permeability. Best practice for
surgeons is to avoid aggressive drilling above 1000 rpm, and to
introduce pulsed drilling to allow some time for heat to dissipate
through the air, bone, and brain tissue. The maximum observed
temperature increase was 21 °C, via an infrared camera.
9.9. Scar Tissue
The displacement of recording or stimulation electrodes from
the main shaft of a neural implant aims to place the elec-
trodes outside of the volume of tissue which is scarred, dying,
or undergoing an immune response.[353] This is also termed
the “kill zone,”[354] and can extend over 20 µm from the
implant surface.[355] Satellite stimulation sites on aggressively
miniaturized “whiskers” extend into healthy tissue, beyond this
region.[353,356] By carefully pacing the electrodes outside of the
area of increased scarring (and by extension impedance, which
will impact the selectivity of the probe), healthy neurons may be
recorded, even after the FBR has encapsulated the main shaft.
Perforations in the BBB cause particles up to 500 nm in size to
amass in this volume of compromised cells:[357] the molecules
which leak through the barrier contribute further to neuronal
degradation. The majority of the tissue damage caused during
probe insertion may be tuned by altering the tip design. If the
tip is both “ultrasharp” and “smooth,”[286] it will slice through tis-
sues with minimal resistance, and as such dimpling, tearing and
stretching will be reduced. The goal is to reduce bleeding and ion
leakage from cells which will be exacerbated by a blunt probe tip.
Employing a “chisel-point” tip, the kill zone is reduced to below
10 µm.[353]
9.10. Modulated Stiffness
A neural implant must be sufficiently stiff to undergo insertion
without buckling or breaking, as well as facilitating precise place-
ment of the electrodes. By contrast, the implant must also be
flexible, with a Young’s modulus which ideally approaches that
of brain tissue.[358] This may be achieved using a bioresorbable
coating, which will dissolve harmlessly on contact with the flu-
ids in the brain,[272] a temporary shuttle, which is removed af-
ter the insertion procedure,[161] or by introducing a mechanically
adaptive substrate material which softens when implanted in-
side the brain.[213,214] Allowing a rigid implant to remain in the
brain invites increased damage from micromotion. Significant
brain shift is also observed in the course of implantation surgery.
The insertion site must be carefully chosen to account for the
movement of the brain up to two weeks after the procedure, dur-
ing which time the probe leads typically deform into a “question
mark” shape.[359] During this brain shift, a rigid probe will not
conform to the displacement of the soft tissue, instead causing
further damage.
10. Conclusion and Future Outlook
In recent years, neural devices have shifted from stiff, wired
implants, such as the Michigan probe, towards miniaturized,
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flexible and novel geometries to encourage successful chronic
recording and stimulation. Accommodating the characteristics
of neural tissues, careful design, fabrication, and implan-
tation methods have created a generation of devices which
show promising results in animal experiments. Specifically,
approaches such as the NeuE and mesh electronics mimic
the soft tissue, integrating with cells. In order to achieve this,
biocompatible, flexible substrates, and encapsulation materials
are employed. While the Young’s modulus of these materials is
typically order of magnitude lower than that of silicon, they still
do not approach that of the brain. While these substrates are
typically suitable to standard cleanroom patterning and etching,
techniques such as transfer printing may be employed to im-
prove the performance of the device. This versatility allows for the
implementation of various stimulation methods: most recently,
optogenetic probes with 𝜇-LEDS. Finally, in order to realize truly
implantable devices, wireless power transfer is crucial to prevent
repeated surgeries, disturbing the device and its surrounding
tissues, and move past the reliance on battery powered medical
implants. With daily advances in research, there is potential
for these novel, sophisticated implants to be implemented for
clinical application, to treat patients with neurological diseases,
and provide better alternatives for the future.
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